Protein Atlas version 13 - 2014.11.06

• Thirteenth major release of the Human Protein Atlas with more than 24000 antibodies, targeting proteins from more than 16,900 human genes (~83% of the human protein-coding genes).

• CAB000069 (pancreatic polypeptide) has been omitted due to product no longer available in provider's catalogue.
• HPA000230 (plexin B3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA000695 (prostaglandin reductase 2) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA001337 (premelanosome protein) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA001351 (EPH receptor B6) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB001988 (ATPase, Na+/K+ transporting, alpha 3 polypeptide) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• CAB002446 (tumor necrosis factor (ligand) superfamily, member 10) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• CAB002743 (collagen, type V, alpha 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• CAB002751 (ATP-binding cassette, sub-family C (CFTR/MRP), member 4) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• CAB002757 (solute carrier family 1 (glutamate/neutral amino acid transporter), member 4) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• CAB002765 (proopiomelanocortin) has been omitted due to product no longer available in provider's catalogue.
• CAB002792 (desmoglein 3) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA002867 (succinate dehydrogenase complex, subunit B, iron sulfur (Ip)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA003066 (serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 11) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA003967 (upstream binding protein 1 (LBP-1a)) has been omitted due to inconsistency with gene/protein characterization data.
• HPA004057 (solute carrier family 6 (neurotransmitter transporter) and member 2) has been omitted due to inconsistency with gene/protein characterization data.
• CAB004421 (G protein-coupled receptor kinase 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB004654 (EPH receptor A4) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA004831 (kinesin family member 1A) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA004909 (protein kinase, AMP-activated and gamma 3 non-catalytic subunit) has been omitted due to inconsistency with gene/protein characterization data.
• CAB005406 (sterol regulatory element binding transcription factor 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB005607 (ATPase, Ca++ transporting, plasma membrane 3) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• CAB005874 (Sp7 transcription factor) has been omitted due to inconsistency with RNA-seq data.
• CAB006331 (melanoregulin) has been omitted due to inconsistency with gene/protein characterization data.
• CAB006825 (S100 calcium binding protein B) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA007210 (solute carrier family 18 (vesicular monoamine transporter), member 1) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA007477 (transducin (beta)-like 2) has been omitted due to inconsistency with RNA-seq data.
• CAB007799 (glutamate receptor, ionotropic and AMPA 3) has been omitted due to inconsistency with gene/protein characterization data.
• HPA007879 (angiopoietin-like 4) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• CAB008367 (drebrin 1) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• CAB008386 (deleted in malignant brain tumors 1) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• CAB008595 (diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• CAB008597 (ferredoxin reductase) has been omitted due to inproducubility.
• CAB008645 (lactotransferrin) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• CAB008671 (superoxide dismutase 3, extracellular) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA008712 (PCDHA1, PCDHA10, PCDHA11, PCDHA12, PCDHA13, PCDHA2, PCDHA3, PCDHA4, PCDHA5, PCDHA6, PCDHA7, PCDHA8, PCDHA9, PCDHAC1, PCDHAC2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB009378 (SRY (sex determining region Y)-box 11) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB009442 (TATA box binding protein) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• CAB010821 (ras homolog family member C) has been omitted due to product no longer available in provider's catalogue.
• HPA010987 (bone morphogenetic protein 10) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA011281 (Fraser syndrome 1) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• CAB011447 (chemokine (C-X-C motif) receptor 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB011623 (TBC1 domain family, member 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA011630 (leucine rich repeat and Ig domain containing 1) has been omitted due to inconsistency with RNA-seq data.
• HPA011742 (ubiquitin specific peptidase 6 (Tre-2 oncogene)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB012222 (peptidyl arginine deiminase and type II) has been omitted due to inconsistency with RNA-seq data.
• CAB012243 (doublecortin) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB012303 (insulin-degrading enzyme) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• CAB012331 (notch 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB012351 (egl-9 family hypoxia-inducible factor 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA012769 (BEN domain containing 2) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA012844 (zinc and ring finger 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB013043 (protein kinase, AMP-activated, alpha 2 catalytic subunit) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA013182 (transmembrane protease, serine 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB013492 (junctophilin 4) has been omitted due to inconsistency with RNA-seq data.
• HPA013570 (galactose-3-O-sulfotransferase 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB013634 (presenilin 2 (Alzheimer disease 4)) has been omitted due to inconsistency with RNA-seq data.
• HPA013959 (6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA014296 (leucine-rich repeat and immunoglobulin-like and transmembrane domains 1) has been omitted due to inconsistency with gene/protein characterization data.
• CAB015165 (melanoma antigen family D and 1) has been omitted due to inconsistency with gene/protein characterization data.
• CAB015168 (troponin T type 1 (skeletal, slow)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA015283 (bromodomain and testis-specific) has been omitted due to inconsistency with RNA-seq data.
• CAB015447 (cytochrome P450, family 26, subfamily A and polypeptide 1) has been omitted due to inconsistency with gene/protein characterization data.
• CAB016097 (ATP-binding cassette, sub-family C (CFTR/MRP), member 1) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• CAB016798 (phospholipase B domain containing 1) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA017135 (ring finger protein 10) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA017602 (potassium channel tetramerization domain containing 17) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA017603 (membrane-associated ring finger (C3HC4) 11) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB017780 (v-myb avian myeloblastosis viral oncogene homolog-like 1) has been omitted due to inconsistency with gene/protein characterization data.
• CAB017820 (chemokine (C-X-C motif) receptor 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB017842 (endothelin receptor type B) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA018040 (claudin 16) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA018105 (NPC1-like 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• CAB018382 (guanine nucleotide binding protein (G protein) and gamma 7) has been omitted due to inconsistency with gene/protein characterization data.
• CAB018959 (feline Gardner-Rasheed sarcoma viral oncogene homolog) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA018994 (kallikrein-related peptidase 7) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• CAB019393 (kallikrein-related peptidase 8) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• CAB019440 (eukaryotic translation initiation factor 4B) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA019754 (IK cytokine and down-regulator of HLA II) has been omitted due to inconsistency with gene/protein characterization data.
• HPA020346 (chromosome 7 open reading frame 31) has been omitted due to inconsistency with RNA-seq data.
• HPA020455 (deleted in lung and esophageal cancer 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA020513 (family with sequence similarity 71 and member F2) has been omitted due to inconsistency with RNA-seq data.
• HPA020639 (dynein, axonemal, heavy chain 9) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• CAB020705 (chordin) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• CAB020814 (EF-hand domain (C-terminal) containing 1) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA021212 (BR serine/threonine kinase 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA021558 (pleckstrin homology domain containing and family M (with RUN domain) member 1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA021640 (leucine rich repeat containing 6) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• CAB022169 (sodium channel, voltage gated, type VIII, alpha subunit) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB022171 (sodium channel, voltage-gated, type X, alpha subunit) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• CAB022226 (pentraxin 3, long) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• CAB022366 (cholinergic receptor, muscarinic 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB022558 (protein phosphatase 1, catalytic subunit and beta isozyme) has been omitted due to inconsistency with gene/protein characterization data.
• CAB022615 (Zic family member 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• CAB022640 (potassium voltage-gated channel, Isk-related family, member 2) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• CAB022754 (trace amine associated receptor 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA023286 (zinc finger and MYND-type containing 15) has been omitted due to inconsistency with gene/protein characterization data.
• HPA023480 (klotho) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA023670 (gasdermin C) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA024172 (regulating synaptic membrane exocytosis 3) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA024301 (sperm-tail PG-rich repeat containing 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA024444 (signal peptide peptidase like 2C) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA024525 (zinc finger protein 536) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA024620 (zinc finger, MYND-type containing 15) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA025038 (nuclear GTPase, germinal center associated) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB025158 (coiled-coil domain containing 80) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• CAB025265 (dual specificity phosphatase 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB025781 (interleukin 22 receptor, alpha 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB025850 (meprin A and beta) has been omitted due to inconsistency with gene/protein characterization data.
• CAB025980 (interleukin 18 binding protein) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• CAB026051 (prokineticin 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB026052 (leukocyte cell-derived chemotaxin 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA026553 (leucine rich repeat containing 40) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA026568 (chromosome 17 open reading frame 105) has been omitted due to inconsistency with RNA-seq data.
• HPA026665 (neuromedin B receptor) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA026922 (stathmin-like 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA027605 (ADAM metallopeptidase domain 18) has been omitted due to inconsistency with RNA-seq data.
• HPA027769 (mucin 12, cell surface associated) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA028039 (component of oligomeric golgi complex 2) has been omitted due to inconsistency with gene/protein characterization data.
• HPA028133 (peptidyl arginine deiminase, type I) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA028495 (HEN1 methyltransferase homolog 1 (Arabidopsis)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA028497 (HEN1 methyltransferase homolog 1 (Arabidopsis)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA028718 (cannabinoid receptor 2 (macrophage)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA028921 (basic helix-loop-helix family and member e40) has been omitted due to inconsistency with gene/protein characterization data.
• HPA029316 (tyrosine aminotransferase) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA029345 (piwi-like RNA-mediated gene silencing 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA029931 (schlafen-like 1) has been omitted due to inconsistency with RNA-seq data.
• HPA030085 (prokineticin 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA030613 (serpin peptidase inhibitor, clade I (pancpin) and member 2) has been omitted due to inconsistency with RNA-seq data.
• HPA030816 (transcription elongation regulator 1-like) has been omitted due to inconsistency with RNA-seq data.
• HPA030852 (DDB1 and CUL4 associated factor 6) has been omitted due to inconsistency with gene/protein characterization data.
• HPA030895 (armadillo repeat containing 12) has been omitted due to inconsistency with RNA-seq data.
• HPA030936 (R3H domain containing 1) has been omitted due to inconsistency with RNA-seq data.
• HPA031724 (heat shock transcription factor 2 binding protein) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA031851 (membrane associated guanylate kinase, WW and PDZ domain containing 1) has been omitted due to inconsistency with RNA-seq data, antibody titration issue and inconsistency with other antibody targeting the same gene.
• HPA031854 (membrane associated guanylate kinase, WW and PDZ domain containing 1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• CAB032510 (cytochrome b-245, beta polypeptide) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• CAB032584 (prion protein 2 (dublet)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• CAB032715 (ribonuclease H1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB033331 (phosphatidic acid phosphatase type 2A) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• CAB034243 (small integral membrane protein 21) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB034279 (claudin 17) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA034664 (Sin3A-associated protein and 130kDa) has been omitted due to inconsistency with gene/protein characterization data.
• HPA034823 (ubiquitin specific peptidase 39) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA034832 (spindle and centriole associated protein 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA034834 (EF-hand domain family and member B) has been omitted due to inconsistency with RNA-seq data.
• CAB034930 (NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 4, 15kDa) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA034941 (reticulon 2) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA035004 (RAD54-like 2 (S. cerevisiae)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA035014 (cytochrome c oxidase subunit VIb polypeptide 2 (testis)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA035088 (syntaxin binding protein 5-like) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA035225 (uridine phosphorylase 2) has been omitted due to inconsistency with RNA-seq data.
• HPA035226 (uridine phosphorylase 2) has been omitted due to inconsistency with RNA-seq data.
• HPA035504 (DnaJ (Hsp40) homolog, subfamily C, member 5 gamma) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA035586 (solute carrier organic anion transporter family, member 1C1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA035610 (MYCBP-associated and testis expressed 1) has been omitted due to inconsistency with RNA-seq data.
• HPA035710 (tudor domain containing 6) has been omitted due to inconsistency with gene/protein characterization data.
• HPA035755 (kinesin family member 3C) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA035757 (poly (ADP-ribose) polymerase family and member 15) has been omitted due to inconsistency with RNA-seq data.
• HPA035903 (SH3 domain containing ring finger 2) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA035915 (phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA036097 (solute carrier family 9, subfamily A (NHE4, cation proton antiporter 4), member 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA036111 (chimerin 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA036298 (myopalladin) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA036341 (androglobin) has been omitted due to inconsistency with RNA-seq data.
• HPA036387 (membrane protein and palmitoylated 4 (MAGUK p55 subfamily member 4)) has been omitted due to inconsistency with gene/protein characterization data.
• HPA036416 (BBS5 and RP11-724O16.1) has been omitted due to inconsistency with RNA-seq data.
• HPA036463 (YTH domain containing 1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA036589 (BMS1 ribosome biogenesis factor) has been omitted due to inconsistency with gene/protein characterization data.
• HPA036598 (solute carrier family 39 (zinc transporter), member 12) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA036954 (nuclear receptor subfamily 2, group E, member 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA036994 (sorbin and SH3 domain containing 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA037006 (tetratricopeptide repeat domain 29) has been omitted due to inconsistency with RNA-seq data.
• CAB037078 (cofilin 2 (muscle)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB037307 (mucolipin 3) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA037689 (leucine rich repeat containing 24) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA037937 (enolase family member 4) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA038020 (heat shock 27kDa protein 3) has been omitted due to inconsistency with gene/protein characterization data.
• HPA038056 (PWWP domain containing 2B) has been omitted due to inconsistency with RNA-seq data.
• HPA038206 (neuregulin 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA038249 (zinc finger and BED-type containing 1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA038264 (heterogeneous nuclear ribonucleoprotein H3 (2H9)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA038428 (G protein-coupled receptor, family C, group 6 and member A) has been omitted due to inconsistency with gene/protein characterization data.
• HPA038478 (B-cell translocation gene 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA038628 (coiled-coil domain containing 33) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA038707 (PWP1 homolog (S. cerevisiae)) has been omitted due to inconsistency with gene/protein characterization data.
• HPA038775 (transmembrane and coiled-coil domains 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA039025 (IQ motif and Sec7 domain 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA039403 (BTB (POZ) domain containing 10) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA039527 (SH3 and cysteine rich domain 3) has been omitted due to inconsistency with RNA-seq data.
• HPA039566 (immunoglobulin-like and fibronectin type III domain containing 1) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA039627 (polymerase (DNA-directed), delta 3, accessory subunit) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA039728 (APC membrane recruitment protein 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA039811 (acetoacetyl-CoA synthetase) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA040216 (peroxisomal biogenesis factor 5-like) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA040533 (carboxypeptidase O) has been omitted due to inconsistency with gene/protein characterization data.
• HPA040721 (integrin beta 1 binding protein (melusin) 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA040790 (SET and MYND domain containing 1) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA040891 (chromosome 11 open reading frame 89) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA041069 (coiled-coil domain containing 11) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA041110 (clathrin, heavy chain-like 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA041126 (chromosome 16 open reading frame 71) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA041627 (interferon-induced protein with tetratricopeptide repeats 1B) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA041634 (5'-nucleotidase domain containing 3) has been omitted due to inconsistency with gene/protein characterization data.
• HPA042131 (chromosome 19 open reading frame 80) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA042382 (SAP30 binding protein) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA042692 (ribonuclease H2 and subunit A) has been omitted due to inconsistency with gene/protein characterization data.
• HPA042694 (CBWD1, CBWD2, CBWD3, CBWD5 and CBWD6) has been omitted due to inconsistency with RNA-seq data.
• HPA042713 (phospholipase A2, group IVF) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA042717 (INO80 complex subunit B) has been omitted due to inconsistency with gene/protein characterization data.
• HPA042764 (THO complex 3) has been omitted due to inconsistency with RNA-seq data.
• HPA043046 (FK506 binding protein 6, 36kDa) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA043131 (coiled-coil domain containing 103) has been omitted due to inconsistency with gene/protein characterization data.
• HPA043223 (occludin/ELL domain containing 1) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA043390 (zinc finger RNA binding protein 2) has been omitted due to inconsistency with gene/protein characterization data.
• HPA043747 (G protein-coupled receptor 119) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA044134 (small muscle protein and X-linked) has been omitted due to inconsistency with gene/protein characterization data.
• HPA044412 (solute carrier family 47 (multidrug and toxin extrusion), member 2) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA044725 (fat storage-inducing transmembrane protein 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA044791 (p21 protein (Cdc42/Rac)-activated kinase 3) has been omitted due to inconsistency with RNA-seq data.
• HPA044909 (jumonji, AT rich interactive domain 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with other antibody targeting the same gene.
• HPA045051 (transmembrane protein 30C) has been omitted due to inconsistency with RNA-seq data.
• HPA045071 (THO complex 3) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA045901 (suppressor of variegation 3-9 homolog 2 (Drosophila)) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA046049 (ribosomal protein L7-like 1) has been omitted due to inconsistency with gene/protein characterization data.
• HPA046360 (IQ motif containing F1) has been omitted due to inconsistency with RNA-seq data.
• HPA046378 (U2 small nuclear RNA auxiliary factor 1-like 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA046827 (transcription factor 15 (basic helix-loop-helix)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA048303 (SPANXN2 and SPANXN3) has been omitted due to inconsistency with RNA-seq data.
• HPA048518 (HMGN2, HMGN4) has been omitted due to inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA048843 (translocase of inner mitochondrial membrane 50 homolog (S. cerevisiae)) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA049111 (hemoglobin, theta 1) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA049143 (pyruvate dehydrogenase phosphatase regulatory subunit) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA049255 (KIR2DL1, KIR2DL2, KIR2DL3, KIR3DL1, KIR3DL2, KIR3DL3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA049306 (derlin 3) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA049740 (centromere protein C) has been omitted due to inconsistency with gene/protein characterization data.
• HPA049769 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 39A) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and antibody titration issue.
• HPA050593 (sperm-tail PG-rich repeat containing 1) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA050820 (adenomatosis polyposis coli 2) has been omitted due to inconsistency with gene/protein characterization data.
• HPA051096 (ADAM metallopeptidase domain 20) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA051247 (dynein regulatory complex subunit 1 homolog (Chlamydomonas)) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA051831 (homeobox D3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA052494 (LY6/PLAUR domain containing 4) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA052560 (Rhox homeobox family, member 1) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA052620 (DnaJ (Hsp40) homolog, subfamily C and member 5 beta) has been omitted due to inconsistency with gene/protein characterization data.
• HPA053509 (sialic acid binding Ig-like lectin 15) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA053713 (T-box 15) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA053835 (Ca++-dependent secretion activator) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA054486 (GINS complex subunit 1 (Psf1 homolog)) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA056442 (olfactomedin 2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA057832 (1-acylglycerol-3-phosphate O-acyltransferase 3) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA059521 (sterile alpha motif domain containing 13) has been omitted due to inconsistency with gene/protein characterization data, inconsistency with RNA-seq data and inconsistency with other antibody targeting the same gene.
• HPA060229 (potassium voltage-gated channel, shaker-related subfamily, member 7) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• CAB009518 (Xanthine dehydrogenase/oxidase) stained images have been omitted due to selective staining in lactating breast, which is unavailable at the moment.
• CAB023353 (Prolactin) has been omitted due to selective staining in the anterior lobe of pituitary gland, which is unavailable at the moment.
• HPA026840 (low affinity sodium-glucose cotransporter) has been omitted due to the lack of selective plasma membrane staining shows instead a nuclear membrane positivity.
• HPA029182 (CCDC169-SOHLH2, SOHLH2) has been omitted due to inconsistency with gene/protein characterization data and inconsistency with RNA-seq data.
• HPA035430 (SPARC-related modular calcium-binding protein 2) has been omitted due to the lack of RNA consistency and the selective staining of goblet cells. Instead a majority of epithelial cells should show secretion.
• HPA042674 (Protein S100-A3) has been omitted due to selective staining in hair follicles, which is unavailable at the moment.
• HPA000839 (gamma-aminobutyric acid (GABA) A receptor, alpha 3) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA001472 (CCCTC-binding factor (zinc finger protein)-like) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA001565 (serpin peptidase inhibitor, clade I (neuroserpin), member 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB001721 (smoothelin) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB001979 (potassium voltage-gated channel, Shab-related subfamily, member 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB002138 & HPA023099 (calbindin 1, 28kDa) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB002584 (acid phosphatase 5, tartrate resistant) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA003040 (megalencephalic leukoencephalopathy with subcortical cysts 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA003425 (trefoil factor 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA003890 (adenosine deaminase, RNA-specific) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA004052 (GTPase activating protein (SH3 domain) binding protein 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB004275 & CAB005334 (phospholipase C, beta 1 (phosphoinositide-specific)) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB004308 (A kinase (PRKA) anchor protein 5) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB004445, HPA046972 & HPA050640 (insulin-like growth factor binding protein 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB004573 & HPA011165 (sirtuin 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB004578 & HPA044582 (surfactant protein D) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB004587 (sequestosome 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA004833 (histidine rich calcium binding protein) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA005670 (distal-less homeobox 5) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA005714 (forkhead box J1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB006846 (recombination signal binding protein for immunoglobulin kappa J region-like) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB006908 & HPA038171 (neurogranin (protein kinase C substrate, RC3)) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA007269 (secretin receptor) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA007338 (retinol binding protein 1, cellular) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA007649 (microtubule-associated protein 1 light chain 3 alpha) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA007656 (CaM kinase-like vesicle-associated) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB007811 (protein phosphatase 1, regulatory (inhibitor) subunit 1A) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA008017 (alpha-1,4-N-acetylglucosaminyltransferase) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA008791 (v-myb avian myeloblastosis viral oncogene homolog-like 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA009084 & HPA018198 (sialic acid binding Ig-like lectin 6) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA009420 (BEN domain containing 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB009449 & HPA017737 (peptidase inhibitor 3, skin-derived) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB009533 & HPA047171 (sterol O-acyltransferase 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA009712 (secreted frizzled-related protein 4) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB009932 (xeroderma pigmentosum, complementation group C) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA009975 (regulator of microtubule dynamics 3) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB010032 (guanine nucleotide binding protein (G protein), beta polypeptide 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB010109 (polymerase (RNA) III (DNA directed) polypeptide G (32kD)) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA010512 (colipase, pancreatic) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA010631 (PILR alpha associated neural protein) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA010689 (prostaglandin E receptor 3 (subtype EP3)) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA011218 (cadherin-related family member 3) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA011273 (heat shock 70kDa protein 12A) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB011595 (forkhead box A1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA011885 (solute carrier family 6 (neutral amino acid transporter), member 18) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB012174 (protein tyrosine phosphatase, non-receptor type 18 (brain-derived)) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA012532 (Uncharacterized protein ) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA012532 (transmembrane emp24 protein transport domain containing 6) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA012928 (transmembrane protein 130) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB012969 (claudin 10) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB012991 (calcium and integrin binding 1 (calmyrin)) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB012993 (plakophilin 3) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA014101 (cholinergic receptor, muscarinic 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA014305 (myomesin 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA014899 & HPA015998 (asialoglycoprotein receptor 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA015077 (catenin (cadherin-associated protein), delta 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB015159 & HPA040171 (transglutaminase 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB015226 (DEK oncogene) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA015322 (zinc finger protein 532) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB015450 (guanylate binding protein 1, interferon-inducible) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB015468 (solute carrier family 22 (organic cation/zwitterion transporter), member 4) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA015581 (protocadherin 9) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB016158 (major histocompatibility complex, class I, G) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB016268 (chemokine (C-X-C motif) receptor 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB016357 (collagen, type VII, alpha 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA016642 (potassium voltage-gated channel, KQT-like subfamily, member 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB016762, HPA020108 & HPA029473 (progestagen-associated endometrial protein) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA016843 (inhibin, beta E) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA017006 (afamin) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA017007 (peptidyl arginine deiminase, type IV) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB017805 (T-cell acute lymphocytic leukemia 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA018412 & HPA018430 (pappalysin 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA018535 & HPA019650 (annexin A13) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB018582 (nitric oxide synthase 1 (neuronal) adaptor protein) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB018632 & HPA030180 (HOP homeobox) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA019075 (solute carrier family 45, member 3) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB019279 (solute carrier family 20 (phosphate transporter), member 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB019380 (Nanog homeobox) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB019384 (homeobox A10) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA019445 (potassium voltage-gated channel, subfamily H (eag-related), member 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA019763 (myosin, light chain 2, regulatory, cardiac, slow) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA019763 (myosin, light chain 10, regulatory) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA019840 (secreted frizzled-related protein 5) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA020280 (aldo-keto reductase family 1, member B10 (aldose reductase)) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA020280 (aldo-keto reductase family 1, member B15) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA020326 (dual specificity phosphatase 16) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA020522 (allograft inflammatory factor 1-like) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA020593 (epoxide hydrolase 1, microsomal (xenobiotic)) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA021083 (synaptonemal complex protein 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA021147 (myeloperoxidase) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA021367 (insulin-like growth factor 2 mRNA binding protein 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA021939 (cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA021955 (carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 4) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB021982 (nicastrin) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA022136 (spermidine/spermine N1-acetyltransferase family member 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB022222 (ELAV like neuron-specific RNA binding protein 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB022725 (glutamate receptor, ionotropic, N-methyl D-aspartate 2A) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA023835 (mucin 12, cell surface associated) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA023940 (family with sequence similarity 83, member G) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA024255 (popeye domain containing 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB024270 (lysine (K)-specific methyltransferase 2A) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA025022 (BTB (POZ) domain containing 17) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA025070, HPA025293 & HPA027233 (chromosome 8 open reading frame 47) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB025416 (runt-related transcription factor 3) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA026317 (gasdermin C) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA027241 (extracellular matrix protein 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA027501 (glycine N-methyltransferase) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA027744 (guanylate binding protein family, member 6) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA028207 (nuclear VCP-like) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA028701 (ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA028971 (amyloid beta (A4) precursor-like protein 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA029919 (plexin A4) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA030033 (PR domain containing 1, with ZNF domain) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA030485 (repetin) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA030608 (distal-less homeobox 6) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA031014 (protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched)) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA031144 (chromosome 1 open reading frame 194) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA031182 (DnaJ (Hsp40) homolog, subfamily C, member 6) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA031342 (calsyntenin 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA031425 (thymocyte selection associated) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA031736 (tau tubulin kinase 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA034504 (chymotrypsin-like) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA034547 (ring finger protein 186) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA034759 (neurexophilin 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB034892 (lipase A, lysosomal acid, cholesterol esterase) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA035107 (Rho GTPase activating protein 26) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA035152 (myelin-associated oligodendrocyte basic protein) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA035472 (galactose mutarotase (aldose 1-epimerase)) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA035640 (collapsin response mediator protein 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA036040 (leucine rich repeat containing 48) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA036112 (family with sequence similarity 162, member B) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA036150 (chromosome 4 open reading frame 40) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA036327 (zinc finger, B-box domain containing) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA036413 (MORC family CW-type zinc finger 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA036801 (protein phosphatase 1, regulatory subunit 36) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB037175 (catenin (cadherin-associated protein), alpha 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB037216 (microtubule-associated protein 1 light chain 3 beta) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB037247 (24-dehydrocholesterol reductase) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA037366 (nucleolar and coiled-body phosphoprotein 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA037493 (dynein, axonemal, heavy chain 12) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA037580 (family with sequence similarity 168, member A) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA037766 (leucine rich repeat containing 23) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA037807 (tetratricopeptide repeat domain 23-like) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA037822 (aldo-keto reductase family 1, member E2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA037829 (armadillo repeat containing 4) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA037975 (transmembrane protein 174) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA038104 (izumo sperm-egg fusion 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA038131 (chromosome 10 open reading frame 67) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA038713 (zinc finger protein 511) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA038713 (proline-rich acidic protein 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA039063 & HPA039064 (microtubule-associated protein 1A) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA039114 (chromosome 1 open reading frame 167) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA039193 (rhophilin associated tail protein 1-like) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA039370 (solute carrier family 24 (sodium/potassium/calcium exchanger), member 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA039451 (myo-inositol oxygenase) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA039486 (dihydroxyacetone kinase 2 homolog (S. cerevisiae)) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA039548 (bleomycin hydrolase) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA039606 (sperm flagellar 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA039686 (calcium-sensing receptor) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA039704 (TIMELESS interacting protein) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA039724 (keratin 78) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA040454 (inositol-trisphosphate 3-kinase A) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB040567 (phosphoserine aminotransferase 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• CAB040578 (mitogen-activated protein kinase 14) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA041351 (calcium channel, voltage-dependent, gamma subunit 8) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA041603 (solute carrier family 5 (sodium/glucose cotransporter), member 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA041773 (cripto, FRL-1, cryptic family 1B) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA041773 (cripto, FRL-1, cryptic family 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA041927 (sperm acrosome associated 4) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA041979 (TP53 target 5) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA042080 (synaptonemal complex central element protein 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA042095 (GLI pathogenesis-related 1 like 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA042496 (tetratricopeptide repeat domain 9B) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA042550 (periplakin) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA043257 (WD repeat domain 54) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA044171 (NHP2 ribonucleoprotein) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA044174 (solute carrier family 22 (organic anion transporter), member 8) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA044194 (DNA nucleotidylexotransferase) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA044371 (gamma-aminobutyric acid (GABA) A receptor, delta) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA044467 (small proline-rich protein 3) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA044502 (deoxynucleotidyltransferase, terminal, interacting protein 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA044682 (perilipin 4) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA044689 (small glutamine-rich tetratricopeptide repeat (TPR)-containing, beta) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA046259 (aquaporin 8) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA046834 (aquaporin 2 (collecting duct)) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA046859 (myosin, light chain 6B, alkali, smooth muscle and non-muscle) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA046859 (myosin, light chain 6, alkali, smooth muscle and non-muscle) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA046859 & HPA051884 (myosin, light chain 4, alkali; atrial, embryonic) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA046859 (myosin, light chain 3, alkali; ventricular, skeletal, slow) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA046859 (myosin, light chain 1, alkali; skeletal, fast) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA047546 (coiled-coil domain containing 96) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA048543 (transmembrane protein 27) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA048592 (branched chain amino-acid transaminase 1, cytosolic) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA049133 (neurexophilin and PC-esterase domain family, member 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA049491 (BPI fold containing family B, member 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA049511 (mitotic spindle positioning) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA051255 (solute carrier family 34 (type II sodium/phosphate contransporter), member 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA051368 (synaptoporin) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA053254 (Aminopeptidase Q ) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA054200 (V-set domain containing T cell activation inhibitor 1) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA059150 (inter-alpha-trypsin inhibitor heavy chain 2) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• HPA003212 has been omitted due to target gene not found in Ensembl.
• HPA014660 has been omitted due to target gene not found in Ensembl.
• HPA023395 has been omitted due to target gene not found in Ensembl.
• HPA027920 has been omitted due to target gene not found in Ensembl.
• HPA037968 has been omitted due to target gene not found in Ensembl.
• HPA042445 has been omitted due to target gene not found in Ensembl.
• HPA044992 has been omitted due to target gene not found in Ensembl.
• HPA047747 has been omitted due to target gene not found in Ensembl.
• HPA049093 has been omitted due to target gene not found in Ensembl.
• HPA049323 has been omitted due to target gene not found in Ensembl.
• HPA053005 has been omitted due to target gene not found in Ensembl.
• HPA060063 has been omitted due to target gene not found in Ensembl.

• CAB000114 has been omitted due to qualitative reasons.
• CAB000668 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA001168 has been omitted due to antibody staining not supported by experimental data.
• HPA001906 has been omitted due to qualitative reasons. An alternative antibody HPA064684 has been added.
• CAB002508 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines. An alternative antibody HPA061418 has been added.
• HPA002647 has been omitted due to qualitative reasons.
• HPA002844 has been omitted due to qualitative reasons.
• HPA003277 has been omitted due to qualitative reasons.
• CAB003859 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB004004 has been omitted due to antibody staining not supported by experimental data.
• CAB004027 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB004311 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB004541 has been omitted due to qualitative reasons.
• CAB004559 has been omitted due to qualitative reasons. An alternative antibody HPA058485 has been added.
• CAB004596 has been omitted due to qualitative reasons. An alternative antibody HPA062160 has been added.
• CAB004603 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB004670 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines. An alternative antibody HPA058593 has been added.
• CAB005044 has been omitted due to qualitative reasons. An alternative antibody CAB009803 has been added.
• CAB005232 has been omitted due to qualitative reasons. An alternative antibody HPA063683 has been added.
• HPA005980 has been omitted due to qualitative reasons. An alternative antibody HPA064792 has been added.
• HPA006007 has been omitted due to qualitative reasons. An alternative antibody HPA064697 has been added.
• HPA006735 has been omitted due to qualitative reasons.
• HPA006748 has been omitted due to qualitative reasons. An alternative antibody HPA006581 has been added.
• HPA006752 has been omitted due to qualitative reasons. An alternative antibody HPA064800 has been added.
• HPA006914 has been omitted due to qualitative reasons.
• HPA007042 has been omitted due to qualitative reasons.
• HPA007644 has been omitted due to qualitative reasons.
• CAB007781 has been omitted due to qualitative reasons. An alternative antibody HPA050746 has been added.
• HPA008214 has been omitted due to antibody staining not supported by experimental data.
• HPA008291 has been omitted due to qualitative reasons.
• HPA008408 has been omitted due to qualitative reasons.
• HPA009078 has been omitted due to qualitative reasons.
• CAB010455 has been omitted due to antibody staining not supported by experimental data.
• HPA010979 has been omitted due to qualitative reasons.
• HPA011422 has been omitted due to qualitative reasons. An alternative antibody HPA058656 has been added.
• CAB011464 has been omitted due to qualitative reasons. An alternative antibody HPA034569 has been added.
• HPA011762 has been omitted due to qualitative reasons. An alternative antibody HPA017086 has been added.
• CAB012283 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA042344 has been added.
• CAB012421 has been omitted due to qualitative reasons.
• HPA012545 has been omitted due to antibody staining not supported by experimental data.
• HPA013335 has been omitted due to qualitative reasons. An alternative antibody HPA013200 has been added.
• HPA014757 has been omitted due to qualitative reasons. An alternative antibody HPA056736 has been added.
• HPA014796 has been omitted due to qualitative reasons.
• HPA014865 has been omitted due to qualitative reasons.
• CAB014882 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines. An alternative antibody HPA042924 has been added.
• CAB014886 has been omitted due to qualitative reasons. An alternative antibody HPA057273 has been added.
• HPA015315 has been omitted due to qualitative reasons.
• HPA015673 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA015742 has been omitted due to qualitative reasons. An alternative antibody HPA056855 has been added.
• CAB016678 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB016787 has been omitted due to qualitative reasons.
• HPA016894 has been omitted due to qualitative reasons. An alternative antibody HPA008877 has been added.
• HPA016965 has been omitted due to qualitative reasons.
• CAB017041 has been omitted due to qualitative reasons.
• CAB017181 has been omitted due to qualitative reasons.
• CAB017479 has been omitted due to qualitative reasons. An alternative antibody HPA022012 has been added.
• CAB017800 has been omitted due to qualitative reasons.
• HPA017936 has been omitted due to qualitative reasons.
• HPA018151 has been omitted due to qualitative reasons.
• HPA018297 has been omitted due to qualitative reasons.
• HPA018487 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA061879 has been added.
• HPA018503 has been omitted due to antibody staining not supported by experimental data.
• CAB018625 has been omitted due to antibody staining not supported by experimental data.
• HPA018841 has been omitted due to qualitative reasons.
• HPA018843 has been omitted due to qualitative reasons.
• HPA018862 has been omitted due to qualitative reasons. An alternative antibody HPA019918 has been added.
• HPA019092 has been omitted due to qualitative reasons.
• HPA019237 has been omitted due to qualitative reasons. An alternative antibody HPA055309 has been added.
• HPA019254 has been omitted due to qualitative reasons.
• HPA019691 has been omitted due to antibody staining not supported by experimental data.
• HPA019803 has been omitted due to qualitative reasons. An alternative antibody HPA024133 has been added.
• HPA019806 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines. An alternative antibody HPA024133 has been added.
• HPA019867 has been omitted due to qualitative reasons. An alternative antibody HPA062933 has been added.
• HPA020017 has been omitted due to qualitative reasons.
• HPA020332 has been omitted due to qualitative reasons.
• HPA020521 has been omitted due to antibody staining not supported by experimental data.
• CAB020828 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB020833 has been omitted due to qualitative reasons. An alternative antibody HPA039867 has been added.
• HPA021076 has been omitted due to antibody staining not supported by experimental data.
• HPA021237 has been omitted due to qualitative reasons. An alternative antibody HPA050448 has been added.
• HPA021602 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• CAB022079 has been omitted due to qualitative reasons.
• HPA022119 has been omitted due to antibody staining not supported by experimental data.
• CAB022682 has been omitted due to qualitative reasons.
• HPA023067 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA023148 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA023420 has been omitted due to qualitative reasons.
• HPA023422 has been omitted due to qualitative reasons.
• HPA023483 has been omitted due to qualitative reasons. An alternative antibody HPA008209 has been added.
• HPA023559 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA023644 has been omitted due to qualitative reasons.
• HPA023646 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA023733 has been omitted due to qualitative reasons.
• HPA024161 has been omitted due to antibody staining not supported by experimental data.
• HPA024243 has been omitted due to qualitative reasons. An alternative antibody HPA057297 has been added.
• HPA024334 has been omitted due to qualitative reasons. An alternative antibody HPA014266 has been added.
• CAB025541 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines. An alternative antibody HPA059381 has been added.
• HPA026283 has been omitted due to qualitative reasons.
• CAB026457 has been omitted due to qualitative reasons.
• HPA026490 has been omitted due to qualitative reasons.
• HPA026506 has been omitted due to antibody staining not supported by experimental data.
• HPA026631 has been omitted due to qualitative reasons.
• HPA026698 has been omitted due to antibody staining not supported by experimental data.
• HPA026874 has been omitted due to qualitative reasons. An alternative antibody HPA061426 has been added.
• HPA027144 has been omitted due to qualitative reasons.
• HPA027318 has been omitted due to qualitative reasons.
• HPA027366 has been omitted due to antibody staining not supported by experimental data.
• HPA027412 has been omitted due to qualitative reasons.
• HPA027760 has been omitted due to qualitative reasons.
• HPA027920 antibody has been omitted due to target gene not found in Ensembl.
• HPA028075 has been omitted due to qualitative reasons.
• HPA028130 has been omitted due to new images pending.
• HPA028215 has been omitted due to qualitative reasons.
• HPA028351 has been omitted due to qualitative reasons. An alternative antibody HPA061086 has been added.
• HPA028795 has been omitted due to qualitative reasons. An alternative antibody HPA060033 has been added.
• HPA028900 has been omitted due to qualitative reasons. An alternative antibody HPA061418 has been added.
• HPA029392 has been omitted due to lack of RNA expression in cell line panel.
• HPA030161 has been omitted due to qualitative reasons.
• HPA030296 has been omitted due to qualitative reasons. An alternative antibody HPA059090 has been added.
• HPA030683 has been omitted due to qualitative reasons. An alternative antibody HPA047590 has been added.
• HPA030917 has been omitted due to qualitative reasons. An alternative antibody HPA049724 has been added.
• HPA030974 has been omitted due to qualitative reasons. An alternative antibody HPA030976 has been added.
• HPA030990 has been omitted due to qualitative reasons. An alternative antibody HPA030989 has been added.
• HPA031020 has been omitted due to qualitative reasons.
• HPA031097 has been omitted due to qualitative reasons. An alternative antibody HPA031096 has been added.
• HPA031100 has been omitted due to qualitative reasons.
• HPA031471 has been omitted due to qualitative reasons. An alternative antibody HPA031470 has been added.
• HPA031515 has been omitted due to qualitative reasons. An alternative antibody HPA057316 has been added.
• HPA031844 has been omitted due to qualitative reasons.
• HPA031845 has been omitted due to qualitative reasons.
• HPA032060 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA032062 has been added.
• CAB033437 has been omitted due to antibody staining not supported by experimental data.
• CAB034296 has been omitted due to qualitative reasons. An alternative antibody HPA032113 has been added.
• HPA034501 has been omitted due to qualitative reasons.
• HPA034868 has been omitted due to qualitative reasons. An alternative antibody HPA056572 has been added.
• HPA034873 has been omitted due to qualitative reasons.
• HPA035027 has been omitted due to qualitative reasons. An alternative antibody HPA035028 has been added.
• HPA035112 has been omitted due to qualitative reasons. An alternative antibody HPA058387 has been added.
• HPA035271 has been omitted due to qualitative reasons. An alternative antibody HPA061397 has been added.
• HPA035303 has been omitted due to qualitative reasons. An alternative antibody HPA056439 has been added.
• HPA035477 has been omitted due to qualitative reasons. An alternative antibody CAB010189 has been added.
• HPA035519 has been omitted due to qualitative reasons. An alternative antibody HPA057964 has been added.
• HPA035608 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA063704 has been added.
• HPA035718 has been omitted due to qualitative reasons. An alternative antibody HPA061866 has been added.
• HPA035815 has been omitted due to qualitative reasons. An alternative antibody HPA035814 has been added.
• HPA035830 has been omitted due to qualitative reasons.
• HPA035863 has been omitted due to qualitative reasons. An alternative antibody HPA058115 has been added.
• HPA035929 has been omitted due to qualitative reasons. An alternative antibody HPA058122 has been added.
• HPA036147 has been omitted due to qualitative reasons.
• HPA036181 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines. An alternative antibody HPA057979 has been added.
• HPA036182 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA057980 has been added.
• HPA036283 has been omitted due to qualitative reasons. An alternative antibody HPA058159 has been added.
• HPA036285 has been omitted due to qualitative reasons. An alternative antibody HPA059111 has been added.
• HPA036401 has been omitted due to antibody staining not supported by experimental data.
• HPA036488 has been omitted due to qualitative reasons.
• HPA036508 has been omitted due to qualitative reasons. An alternative antibody HPA058148 has been added.
• HPA036554 has been omitted due to qualitative reasons.
• HPA036724 has been omitted due to antibody staining not supported by experimental data.
• HPA036739 has been omitted due to qualitative reasons. An alternative antibody HPA036738 has been added.
• HPA036825 has been omitted due to qualitative reasons.
• HPA036867 has been omitted due to qualitative reasons. An alternative antibody HPA058180 has been added.
• HPA036888 has been omitted due to qualitative reasons.
• HPA036943 has been omitted due to qualitative reasons.
• HPA036977 has been omitted due to qualitative reasons.
• HPA036994 has been omitted due to antibody staining not supported by experimental data.
• HPA036996 has been omitted due to qualitative reasons. An alternative antibody HPA044869 has been added.
• CAB037058 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA053198 has been added.
• CAB037178 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA037410 has been omitted due to qualitative reasons. An alternative antibody HPA061665 has been added.
• HPA037477 has been omitted due to qualitative reasons.
• HPA037604 has been omitted due to new images pending.
• HPA037674 has been omitted due to qualitative reasons. An alternative antibody HPA059332 has been added.
• HPA037708 has been omitted due to qualitative reasons.
• HPA037774 has been omitted due to qualitative reasons.
• HPA037863 has been omitted due to qualitative reasons.
• HPA037909 has been omitted due to qualitative reasons. An alternative antibody HPA057550 has been added.
• HPA038042 has been omitted due to qualitative reasons. An alternative antibody HPA061547 has been added.
• HPA038132 has been omitted due to qualitative reasons. An alternative antibody HPA056807 has been added.
• HPA038147 has been omitted due to qualitative reasons.
• HPA038154 has been omitted due to qualitative reasons. An alternative antibody HPA056913 has been added.
• HPA038312 has been omitted due to qualitative reasons.
• HPA038397 has been omitted due to antibody staining not supported by experimental data.
• HPA038499 has been omitted due to qualitative reasons. An alternative antibody HPA057568 has been added.
• HPA038579 has been omitted due to qualitative reasons. An alternative antibody HPA038578 has been added.
• HPA038588 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA038605 has been omitted due to qualitative reasons. An alternative antibody HPA038607 has been added.
• HPA038620 has been omitted due to qualitative reasons. An alternative antibody HPA058232 has been added.
• HPA038642 has been omitted due to qualitative reasons.
• HPA038694 has been omitted due to qualitative reasons. An alternative antibody HPA038695 has been added.
• HPA038730 has been omitted due to antibody staining not supported by experimental data.
• HPA038779 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA062015 has been added.
• HPA038827 has been omitted due to qualitative reasons. An alternative antibody HPA061763 has been added.
• HPA038907 has been omitted due to qualitative reasons.
• HPA039196 has been omitted due to antibody staining not supported by experimental data.
• HPA039281 has been omitted due to qualitative reasons.
• HPA039338 has been omitted due to qualitative reasons. An alternative antibody HPA059327 has been added.
• HPA039353 has been omitted due to qualitative reasons. An alternative antibody HPA061517 has been added.
• HPA039356 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA039430 has been omitted due to qualitative reasons. An alternative antibody CAB009567 has been added.
• HPA039434 has been omitted due to qualitative reasons. An alternative antibody HPA059327 has been added.
• HPA039457 has been omitted due to qualitative reasons. An alternative antibody HPA039801 has been added.
• HPA039547 has been omitted due to antibody staining not supported by experimental data.
• HPA039699 has been omitted due to lack of RNA expression in cell line panel.
• HPA039811 has been omitted due to qualitative reasons. An alternative antibody HPA058815 has been added.
• HPA039918 has been omitted due to qualitative reasons. An alternative antibody HPA041717 has been added.
• HPA039985 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA040111 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA040152 has been omitted due to qualitative reasons. An alternative antibody HPA044081 has been added.
• HPA040166 has been omitted due to qualitative reasons. An alternative antibody HPA064403 has been added.
• HPA040226 has been omitted due to qualitative reasons. An alternative antibody HPA040205 has been added.
• HPA040279 has been omitted due to qualitative reasons.
• HPA040596 has been omitted due to qualitative reasons. An alternative antibody HPA061753 has been added.
• HPA040697 has been omitted due to qualitative reasons. An alternative antibody HPA059818 has been added.
• HPA040764 has been omitted due to qualitative reasons. An alternative antibody HPA041091 has been added.
• HPA040782 has been omitted due to antibody staining not supported by experimental data.
• HPA040811 has been omitted due to qualitative reasons. An alternative antibody HPA042059 has been added.
• HPA040827 has been omitted due to lack of RNA expression in cell line panel.
• HPA041197 has been omitted due to qualitative reasons.
• HPA041737 has been omitted due to antibody staining not supported by experimental data.
• HPA041786 has been omitted due to qualitative reasons. An alternative antibody HPA041699 has been added.
• HPA041801 has been omitted due to qualitative reasons. An alternative antibody HPA058763 has been added.
• HPA041815 has been omitted due to qualitative reasons.
• HPA041972 has been omitted due to qualitative reasons.
• HPA042102 has been omitted due to qualitative reasons. An alternative antibody CAB005268 has been added.
• HPA042197 has been omitted due to antibody staining not supported by experimental data.
• HPA042278 has been omitted due to qualitative reasons. An alternative antibody HPA058183 has been added.
• HPA042445 antibody has been omitted due to target gene not found in Ensembl.
• HPA042578 has been omitted due to qualitative reasons.
• HPA042593 has been omitted due to qualitative reasons.
• HPA042606 has been omitted due to qualitative reasons. An alternative antibody HPA057998 has been added.
• HPA042620 has been omitted due to qualitative reasons. An alternative antibody HPA057954 has been added.
• HPA042758 has been omitted due to qualitative reasons. An alternative antibody HPA042839 has been added.
• HPA042817 has been omitted due to qualitative reasons.
• HPA043088 has been omitted due to qualitative reasons.
• HPA043480 has been omitted due to qualitative reasons.
• HPA043678 has been omitted due to antibody staining not supported by experimental data.
• HPA043767 has been omitted due to qualitative reasons. An alternative antibody HPA063554 has been added.
• HPA043887 has been omitted due to qualitative reasons. An alternative antibody HPA041454 has been added.
• HPA044012 has been omitted due to qualitative reasons. An alternative antibody HPA054615 has been added.
• HPA044105 has been omitted due to qualitative reasons.
• HPA044311 has been omitted due to qualitative reasons. An alternative antibody HPA053459 has been added.
• HPA045095 has been omitted due to qualitative reasons.
• HPA045498 has been omitted due to qualitative reasons. An alternative antibody HPA058028 has been added.
• HPA045647 has been omitted due to qualitative reasons. An alternative antibody CAB005389 has been added.
• HPA045778 has been omitted due to qualitative reasons. An alternative antibody HPA061693 has been added.
• HPA045784 has been omitted due to qualitative reasons. An alternative antibody HPA064323 has been added.
• HPA046138 has been omitted due to qualitative reasons. An alternative antibody HPA058368 has been added.
• HPA046378 has been omitted due to qualitative reasons. An alternative antibody HPA061644 has been added.
• HPA046558 has been omitted due to antibody staining not supported by experimental data.
• HPA046634 has been omitted due to qualitative reasons. An alternative antibody HPA029043 has been added.
• HPA046723 has been omitted due to qualitative reasons.
• HPA046964 has been omitted due to antibody showing negative and/or unspecific staining in all cell lines.
• HPA047175 has been omitted due to antibody staining not supported by experimental data.
• HPA047205 has been omitted due to qualitative reasons. An alternative antibody HPA057719 has been added.
• HPA047596 has been omitted due to qualitative reasons. An alternative antibody CAB018762 has been added.
• HPA047657 has been omitted due to qualitative reasons. An alternative antibody HPA057176 has been added.
• HPA047658 has been omitted due to qualitative reasons. An alternative antibody HPA058392 has been added.
• HPA047928 has been omitted due to antibody staining not supported by experimental data.
• HPA047954 has been omitted due to antibody staining not supported by experimental data.
• HPA048059 has been omitted due to qualitative reasons. An alternative antibody HPA058036 has been added.
• HPA048142 has been omitted due to qualitative reasons. An alternative antibody HPA061191 has been added.
• HPA048457 has been omitted due to qualitative reasons. An alternative antibody HPA060129 has been added.
• HPA048459 has been omitted due to antibody staining not supported by experimental data.
• HPA048474 has been omitted due to qualitative reasons.
• HPA048724 has been omitted due to qualitative reasons. An alternative antibody HPA048289 has been added.
• HPA048772 has been omitted due to qualitative reasons. An alternative antibody HPA060520 has been added.
• HPA048921 has been omitted due to qualitative reasons. An alternative antibody HPA058894 has been added.
• HPA049163 has been omitted due to qualitative reasons. An alternative antibody HPA058265 has been added.
• HPA049167 has been omitted due to qualitative reasons. An alternative antibody HPA065197 has been added.
• HPA049250 has been omitted due to antibody staining not supported by experimental data.
• HPA049307 has been omitted due to qualitative reasons. An alternative antibody HPA056814 has been added.
• HPA049317 has been omitted due to qualitative reasons. An alternative antibody HPA058381 has been added.
• HPA049362 has been omitted due to qualitative reasons. An alternative antibody HPA061785 has been added.
• HPA049528 has been omitted due to qualitative reasons. An alternative antibody HPA059910 has been added.
• HPA049563 has been omitted due to qualitative reasons. An alternative antibody HPA057768 has been added.
• HPA049840 has been omitted due to qualitative reasons. An alternative antibody HPA062236 has been added.
• HPA049957 has been omitted due to qualitative reasons. An alternative antibody HPA057770 has been added.
• HPA050159 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA055007 has been added.
• HPA050169 has been omitted due to qualitative reasons. An alternative antibody HPA047641 has been added.
• HPA050392 has been omitted due to antibody staining not supported by experimental data.
• HPA050404 has been omitted due to antibody staining not supported by experimental data.
• HPA050547 has been omitted due to qualitative reasons.
• HPA050590 has been omitted due to qualitative reasons. An alternative antibody HPA045760 has been added.
• HPA050694 has been omitted due to qualitative reasons. An alternative antibody HPA057676 has been added.
• HPA050711 has been omitted due to qualitative reasons. An alternative antibody HPA059530 has been added.
• HPA050726 has been omitted due to qualitative reasons. An alternative antibody HPA019866 has been added.
• HPA051082 has been omitted due to qualitative reasons. An alternative antibody HPA061678 has been added.
• HPA051161 has been omitted due to qualitative reasons. An alternative antibody HPA063142 has been added.
• HPA051230 has been omitted due to qualitative reasons. An alternative antibody HPA059742 has been added.
• HPA051340 has been omitted due to qualitative reasons. An alternative antibody HPA055387 has been added.
• HPA051636 has been omitted due to qualitative reasons. An alternative antibody HPA057593 has been added.
• HPA051861 has been omitted due to qualitative reasons. An alternative antibody HPA061232 has been added.
• HPA051886 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA063748 has been added.
• HPA051956 has been omitted due to qualitative reasons.
• HPA052058 has been omitted due to qualitative reasons. An alternative antibody HPA024379 has been added.
• HPA052140 has been omitted due to qualitative reasons. An alternative antibody HPA020523 has been added.
• HPA052182 has been omitted due to qualitative reasons.
• HPA052256 has been omitted due to qualitative reasons. An alternative antibody HPA063044 has been added.
• HPA052381 has been omitted due to qualitative reasons. An alternative antibody HPA022132 has been added.
• HPA052408 has been omitted due to qualitative reasons. An alternative antibody HPA054902 has been added.
• HPA052455 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA061391 has been added.
• HPA052509 has been omitted due to qualitative reasons. An alternative antibody HPA045245 has been added.
• HPA052910 has been omitted due to qualitative reasons. An alternative antibody HPA020891 has been added.
• HPA053117 has been omitted due to qualitative reasons. An alternative antibody HPA063344 has been added.
• HPA053665 has been omitted due to qualitative reasons. An alternative antibody HPA025711 has been added.
• HPA053700 has been omitted due to qualitative reasons. An alternative antibody HPA007290 has been added.
• HPA053739 has been omitted due to qualitative reasons. An alternative antibody HPA046109 has been added.
• HPA053776 has been omitted due to qualitative reasons. An alternative antibody HPA063416 has been added.
• HPA053875 has been omitted due to qualitative reasons. An alternative antibody HPA060744 has been added.
• HPA053894 has been omitted due to antibody staining not supported by experimental data.
• HPA053966 has been omitted due to qualitative reasons. An alternative antibody HPA056028 has been added.
• HPA053970 has been omitted due to antibody staining not supported by experimental data. An alternative antibody HPA058655 has been added.
• HPA054000 has been omitted due to qualitative reasons. An alternative antibody HPA061478 has been added.
• HPA054004 has been omitted due to qualitative reasons. An alternative antibody HPA059601 has been added.
• HPA054007 has been omitted due to qualitative reasons. An alternative antibody HPA063990 has been added.
• HPA054519 has been omitted due to qualitative reasons. An alternative antibody HPA059935 has been added.
• HPA054536 has been omitted due to qualitative reasons. An alternative antibody HPA061199 has been added.
• HPA054596 has been omitted due to qualitative reasons.
• HPA054777 has been omitted due to qualitative reasons.
• HPA054798 has been omitted due to new images pending.
• HPA054885 has been omitted due to antibody staining not supported by experimental data.
• HPA054894 has been omitted due to qualitative reasons. An alternative antibody HPA059540 has been added.
• HPA054903 has been omitted due to qualitative reasons. An alternative antibody HPA057276 has been added.
• HPA054975 has been omitted due to qualitative reasons. An alternative antibody HPA034569 has been added.
• HPA055374 has been omitted due to qualitative reasons. An alternative antibody HPA065263 has been added.
• HPA055545 has been omitted due to qualitative reasons. An alternative antibody HPA064930 has been added.
• HPA055661 has been omitted due to qualitative reasons. An alternative antibody HPA042449 has been added.
• HPA055748 has been omitted due to qualitative reasons. An alternative antibody HPA062833 has been added.
• HPA055853 has been omitted due to qualitative reasons. An alternative antibody HPA030681 has been added.
• HPA055876 has been omitted due to qualitative reasons.
• HPA055913 has been omitted due to qualitative reasons.
• HPA056104 has been omitted due to antibody staining not supported by experimental data.
• HPA056187 has been omitted due to antibody staining not supported by experimental data.
• HPA056706 has been omitted due to qualitative reasons. An alternative antibody HPA043051 has been added.
• HPA056892 has been omitted due to qualitative reasons. An alternative antibody HPA059910 has been added.
• HPA057178 has been omitted due to qualitative reasons. An alternative antibody HPA015270 has been added.
• HPA058412 has been omitted due to qualitative reasons. An alternative antibody HPA031949 has been added.

Protein Atlas version 12 - 2013.12.05

• Twelfth major release of the Human Protein Atlas with more than 21,900 antibodies, targeting proteins from more than 16,600 human genes (~82% of the human protein-coding genes).
• 27 tissues have been analyzed in the RNAseq assay: adipose tissue, adrenal gland, appendix, bone marrow, cerebral cortex, colon, duodenum, esophagus, gallbladder, heart muscle, kidney, liver, lung, lymph node, ovary, pancreas, placenta, prostate, salivary gland, skin, small intestine, spleen, stomach, testis, thyroid gland, urinary bladder and uterus.
• 33 new cell lines (total 44) have been analyzed in the RNAseq assay: AN3-CA, BEWO, CAPAN-2, Daudi, EFO-21, HaCaT, HDLM-2, HEL, HL-60, HMC-1, K-562, Karpas-707, MOLT-4, NB-4, NTERA-2, REH, RH-30, RPMI-8226, SCLC-21H, SH-SY5Y, SiHa, SK-BR-3, SK-MEL-30, TIME, THP-1, U-138 MG, U-2197, U-266/70, U-266/84, U-698, U-87 MG, U-937 and WM-115.
• The identity of cell line KM3 has been adjusted according to information from DSMZ of KM3 being a misidentified cell line. The true identity is given as REH. DSMZ - False leukemia and lymphoma cell lines.
• Medulla blastoma cell line D341 Med was omitted from the Human Protein Atlas due to an unsatisfactory quality of the cell line images. Both cell number and morphology was considered insufficient for representation on the atlas.
• The serpin peptidase inhibitor, clade B (ovalbumin), member 3 (CAB036006) antibody has been omitted due to lack of positivity in squamous epithelia. CAB018772 shows positivity in squamous epithelia.
• The oligodendrocyte transcription factor 1 (CAB025474) antibody has been omitted due to lack of predominant positivity in the brain.
• The lectin, galactoside-binding, soluble, 13 (HPA046803) antibody has been omitted due to lack of predominant positivity in placenta.
• The HGF activator (CAB005215) antibody has been omitted due to lack of positivity in plasma. Alternative antibodies (HPA058279 & HPA059076) showing positivity in plasma have been added.
• The C-type lectin domain family 1, member B (CAB024956) antibody has been omitted due to lack of positivity in liver and leukocytes. An alternative antibody (HPA051108) showing positivity in leukocytes has been added.
• The inter-alpha-trypsin inhibitor heavy chain 2 (CAB008644) antibody has been omitted due to lack of positivity in plasma. An alternative antibody (HPA059150) showing positivity in plasma has been added.
• The keratin associated protein 10-1 (CAB034209 & CAB034210) antibodies have been omitted due to lack of predominant positivity in keratin.
• The apolipoprotein A-V (CAB032848) antibody has been omitted due to lack of positivity in plasma.
• The ryanodine receptor 1 (skeletal) (CAB006835) antibody has been omitted due to lack of positivity in skeletal muscle and CNS. An alternative antibody (HPA056416) showing positivity in skeletal muscle and CNS has been added.
• The noggin (CAB011490) antibody has been omitted due to lack of secreted positivity. An alternative antibody (HPA061318) showing secreted positivity has been added.
• The somatostatin receptor 1 (CAB009773) antibody has been omitted due to lack of membranous positivity. An alternative antibody (HPA031506) showing membranous positivity has been added.
• The forkhead box O4 (CAB037151) antibody has been omitted due to lack of nuclear positivity. An alternative antibody (HPA040232) showing nuclear positivity has been added.
• The growth arrest-specific 2 (CAB024194) antibody has been omitted due to weak positivity in liver compared to other tissues. An alternative antibody (HPA058904) showing more specificity towards liver has been added.
• The cathepsin E (HPA008021) antibody has been omitted due to weak positivity in stomach and intestine compared to other tissues. Alternative antibodies (HPA012940 & CAB032687) showing positivity mainly in stomach and intestine have been added.
• The phospholipase A2, group IB (pancreas) (CAB022329) antibody has been omitted due to lack of predominant staining in pancreas. Alternative antibodies (HPA060803 & HPA047822) showing predominant staining in pancreas have been added.
• The nephroblastoma overexpressed (HPA018449) antibody has been omitted due to lack of predominant staining in adrenal gland. HPA019684 shows predominant staining in adrenal gland.
• The gamma-aminobutyric acid (GABA) A receptor, alpha 1 (CAB001963) antibody has been omitted due to lack of predominant staining in CNS. An alternative antibody (HPA055746) showing predominant staining in CNS has been added.
• The polycystic kidney and hepatic disease 1 (autosomal recessive) (HPA031229) antibody has been omitted due to lack of predominant staining in kidney. HPA031227 shows positivity predominantly in kidney.
• The coiled-coil domain containing 62 (HPA039021) antibody has been omitted due to lack of predominant staining in testis. An alternative antibody (HPA058741) showing positivity in testis has been added.
• The placenta-specific 1-like (HPA039820) antibody has been omitted due to lack of predominant staining in testis. An alternative antibody (HPA050914) showing positivity in testis has been added.
• The Rho GDP dissociation inhibitor (GDI) alpha (CAB004561) antibody has been omitted due to selective staining in leukocytes when it should stain in many tissues.
• The aquaporin 2 (collecting duct) (CAB009866) antibody has been omitted due to lack of predominant staining in kidney. An alternative antibody (HPA046834) showing positivity in kidney has been added.
• The growth hormone releasing hormone receptor (CAB005620) antibody has been omitted due to a general staining pattern when it predominantly should stain pituitary gland.
• The chromodomain helicase DNA binding protein 8 (HPA000849) antibody has been omitted due to cytoplasmic staining when it should stain nucleus.
• The neurotensin (CAB022386) antibody has been omitted due to general staining when it predominantly should stain neuroendocrine cells in intestine . An alternative antibody (HPA026664) showing selective staining in neuroendocrine cells has been added.
• The cytochrome P450, family 1, subfamily A, polypeptide 2 (CAB015446) antibody has been omitted due to lack of predominant staining in liver. CAB016531 shows predominant staining in liver.
• The capping protein (actin filament) muscle Z-line, alpha 3 (HPA038687) antibody has been omitted due to lack of predominant staining in testis.
• The golgin A6 family, member A, golgin A6 family, member B, golgin A6 family, member C, golgin A6 family, member D (HPA045056) antibody has been omitted due to lack of predominant staining in testis. An alternative antibody (HPA050087) showing predominant staining in testis has been added.
• The P antigen family, member 2 (prostate associated), P antigen family, member 2B, P antigen family, member 5 (prostate associated) (HPA045952) antibody has been omitted due to lack of predominant staining in testis. An alternative antibody (HPA052619) showing predominant staining in testis has been added.
• The myosin binding protein H-like (HPA027623) antibody has been omitted due to lack of predominant staining in heart.
• The tetratricopeptide repeat domain 21A (HPA035511) antibody has been omitted due to lack of predominant staining in testis. An alternative antibody (HPA035510) showing predominant positivity in testis has been added.
• The surfactant associated 2 (HPA056272) antibody has been omitted due to lack of predominant staining in lung.
• The EGF-like-domain, multiple 6 (HPA006003) antibody has been omitted due to overlapping antigen with antibody HPA001838 targeting the same gene (disagreement with the concept of independent antibodies for quality assurance).
• The von Willebrand factor A domain containing 3B (HPA036701) antibody has been omitted due to lack of predominant positivity in testis, fallopian tube and lung.
• The paired box 3 (CAB013466) antibody has been omitted due to lack of nuclear staining.
• The outer dense fiber of sperm tails 4 (HPA016621) antibody has been omitted due to lack of predominant staining in testis.
• The serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 11 (HPA055433) antibody has been omitted due to lack of secreted positivity or positivity in liver.
• The secreted phosphoprotein 2, 24kDa (HPA049360) antibody has been omitted due to lack of secreted positivity or positivity in liver.
• The solute carrier family 22 (organic anion transporter), member 9 (HPA014862) antibody has been omitted due to lack of positivity in liver.
• The hepatic and glial cell adhesion molecule (HPA017613) antibody has been omitted due to lack of positivity in liver and CNS. CAB025486 shows positivity in liver and CNS.
• The leiomodin 2 (cardiac) (HPA053789) antibody has been omitted due to lack of predominant positivity in heart and skeletal muscle. An alternative antibody (HPA051039) showing predominant positivity in heart and skeletal muscle has been added.
• The F-box protein 40 (HPA002884) antibody has been omitted due to lack of predominant positivity in heart and skeletal muscle.
• The FERM and PDZ domain containing 2 (HPA018872) antibody has been omitted due to nuclear staining when it should stain in the membranes. An alternative antibody (HPA045059) showing positivity in membranes has been added.
• The troponin I type 3 (cardiac) (CAB018644) antibody has been omitted due to lack of predominant staining in heart muscle. HPA046428 shows predominant staining in heart muscle.
• The topoisomerase (DNA) III beta (CAB009198) antibody has been omitted due to lack of nuclear staining.
• The chymotrypsin-like elastase family, member 2B, chymotrypsin-like elastase family, member 2A (HPA047270) antibody has been omitted due to lack of staining in pancreas.
• The phospholipase A2, group IVE (HPA040329) antibody has been omitted due to lack of predominant staining in squamous epithelia. An alternative antibody (HPA041105) showing predominant positivity in squamous epithelia has been added.
• The spermatid maturation 1 (HPA017723) antibody has been omitted due to lack of predominant staining in testis.
• The melanoma antigen family C, 2 (HPA048903) antibody has been omitted due to lack of predominant staining in testis among normal tissues. An alternative antibody (HPA062230) showing specific staining in testis has been added.
• The phospholipase C, zeta 1 (HPA040732) antibody has been omitted due to lack of predominant staining in testis.
• The kelch-like family member 32 (HPA043872) antibody has been omitted due to lack of predominant staining in CNS. HPA039150 shows positivity in CNS.
• The ADP-ribosylhydrolase like 1 (HPA041558 & HPA043951) antibodies have been omitted due to lack of predominant staining in heart muscle.
• The chemokine (C-C motif) ligand 27 (HPA042918) antibody has been omitted due to lack of predominant staining in skin.
• The odontogenic, ameloblast asssociated (HPA036543) antibody has been omitted due to lack of positivity in secreted material.
• The coagulation factor IX (HPA000254) antibody has been omitted due to lack of positivity in plasma.
• The IGF-like family member 1 (HPA014270) antibody has been omitted and replaced with antibody HPA014001 targeting the same gene (disagreement with the concept of independent antibodies for quality assurance).
• The kelch-like family member 10 (HPA023853) antibody has been omitted due to lack of positivity in testis.
• The keratin 2 (HPA006299) antibody has been omitted due to lack of predominant staining in skin. An alternative antibody (CAB037321) showing predominant staining in skin has been added.
• The submaxillary gland androgen regulated protein 3A (HPA044567) antibody has been omitted due to lack of predominant staining in salivary gland.
• The cysteine dioxygenase type 1 (HPA036573) antibody has been omitted due to lack of predominant staining in liver. An additional antibody (HPA057503) showing predominant positivity in liver has been added.
• The calcium channel, voltage-dependent, alpha 2/delta subunit 3 (HPA030850) antibody has been omitted due to lack of predominant staining in brain and heart muscle.
• The doublecortin domain containing 1 (HPA032083 & HPA039014) antibodies have been omitted due to lack of predominant staining in testis and fallopian tube.
• The calcitonin-related polypeptide alpha (CAB000005) has been omitted due to negative staining in thyroidea, most likely due to lack of parafollicular cells, the certain cell type that should express the protein in the tested tissue.
• The gasdermin C (HPA024767) antibody has been omitted due to lack of predominant staining in spleen and esophagus.
• The neurotrophin 4 (CAB010167) antibody has been omitted due to lack of positivity in secreted material. HPA057435 shows positivity in secreted material.
• The angiogenin, ribonuclease, RNase A family, 5 (CAB013673) has been omitted since it has been discontinued by the commercial distributor.
• The mucin 16, cell surface associated (HPA026659 & HPA050015) antibodies have been been omitted due to lack of positivity in uterus and fallopian tube.
• The calcium channel, voltage-dependent, L type, alpha 1S subunit (CAB009507) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The gasdermin B (CAB013681) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The synaptotagmin binding, cytoplasmic RNA interacting protein (CAB010895) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The Src homology 2 domain containing adaptor protein B (CAB010161) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The ankyrin 3, node of Ranvier (ankyrin G) (CAB015179) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The alcohol dehydrogenase 1A (class I), alpha polypeptide (CAB009562) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The ELOVL fatty acid elongase 5 (CAB017042) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The calsequestrin 2 (cardiac muscle) (HPA027285) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The methylcrotonoyl-CoA carboxylase 1 (alpha) (HPA008310) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The carbonic anhydrase III, muscle specific (HPA026700) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The APOBEC1 complementation factor (HPA037779) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The solute carrier family 6 (neurotransmitter transporter, GABA), member 1 (HPA013341) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The cellular repressor of E1A-stimulated genes 2 (HPA038224) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The etal and adult testis expressed 1 (HPA034604) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The chromosome 2 open reading frame 57 (HPA049917) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The chromosome 9 open reading frame 1 (HPA015504) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The family with sequence similarity 194, member A (HPA048373) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The alpha-2-glycoprotein 1, zinc-binding (HPA012582) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The P antigen family, member 4 (prostate associated) (HPA023880) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The chloride intracellular channel 3 (HPA005963) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The paternally expressed 10 (HPA051038) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The runt-related transcription factor 2 (HPA022040) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The ligodendrocytic myelin paranodal and inner loop protein (HPA014372) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The cystatin E/M (CAB019316) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The S100 calcium binding protein G (CAB017688) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The solute carrier family 5 (sodium/glucose cotransporter), member 1 (CAB015467) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The KiSS-1 metastasis-suppressor (CAB017775) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The lin-28 homolog B (C. elegans) (HPA036630) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The delta-like 1 homolog (Drosophila) (CAB005872) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The surfactant protein A1 (CAB016793) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The polycystic kidney and hepatic disease 1 (autosomal recessive) (HPA031227) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The coiled-coil domain containing 39 (HPA035364) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The insulin-like 5 (HPA030100) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The defensin, alpha 6, Paneth cell-specific (HPA019462) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The gastric inhibitory polypeptide (HPA021612) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The glycoprotein 2 (zymogen granule membrane) (HPA015739 & HPA016668) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The SH3-domain GRB2-like 3 (HPA039381) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The fibronectin type III and SPRY domain containing 1 (HPA043141) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The syntaxin 7 (HPA001467) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The chromogranin A (parathyroid secretory protein 1) (HPA017369) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The carbonic anhydrase XII (HPA008773) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The podocalyxin-like (HPA002110) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The transthyretin (HPA002550) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The ermin, ERM-like protein (HPA038295 & HPA038296) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The major histocompatibility complex, class I, G (CAB016158) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 (HPA014963) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The aquaporin 4 (HPA014784 & CAB005079) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The calcyphosine-like (HPA058495) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The phenylethanolamine N-methyltransferase (CAB017029) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The guanylate cyclase activator 2A (guanylin) (HPA018215) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The nephroblastoma overexpressed (HPA019684) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The chromosome 1 open reading frame 222 (HPA028521 & HPA029274) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The ankyrin repeat domain 45 (HPA031655, HPA031656 & HPA031657) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The aquaporin 6, kidney specific (HPA015278) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The coiled-coil domain containing 17 (HPA028338) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The solute carrier family 12 (sodium/chloride transporters), member 3 (HPA028748) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The TGFB-induced factor homeobox 2-like, X-linked (HPA034543) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The calcium channel, voltage-dependent, alpha 2/delta subunit 2 (HPA034771) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The dimethylglycine dehydrogenase (HPA036442) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The fibrinogen alpha chain (CAB016776 & HPA051370) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The tubulin polymerization promoting protein (HPA036575) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The transmembrane protein 174 (HPA037975) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The solute carrier family 34 (type II sodium/phosphate contransporter), member 2 (HPA037989) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The cation channel, sperm associated 4 (HPA045257) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The late cornified envelope 6A (HPA046376) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The chromosome 12 open reading frame 56 (HPA056986) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The centromere protein H (HPA036494) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The cytochrome P450, family 11, subfamily B, polypeptide 1 & 2 (HPA049171) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The hepatoma derived growth factor-like 1 (HPA045679) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2 (CAB004616) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The MORC family CW-type zinc finger 4 (HPA000395) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The sulfotransferase family, cytosolic, 1B, member 1 (HPA002107) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2 (CAB004616) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled (HPA014011) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The troponin T type 2 (cardiac) (HPA015774, HPA017888) stained images have been omitted and replaced with images from a more recent staining with the same antibodies.
• The cAMP-regulated phosphoprotein, 21kDa (HPA017303) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor) (CAB017830) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The G protein-coupled receptor 182 (HPA027037) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The G protein-coupled receptor 32 (HPA030330) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The SHC SH2-domain binding protein 1-like (HPA036125) stained images have been omitted and replaced with images from a more recent staining with the same antibodies.
• The spermatogenesis associated 16 (HPA037884) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The chromosome 10 open reading frame 53 (HPA037951) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The leucine rich repeat containing 38 (HPA038778) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The spermatid associated (HPA040046 & HPA039359) stained images have been omitted and replaced with images from a more recent staining with the same antibodies.
• The trehalase (brush-border membrane glycoprotein) (HPA039913) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The zymogen granule protein 16B (HPA041125) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The sarcalumenin (HPA041535) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The proline rich 4 (lacrimal) (HPA042133) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The collagen, type XVII, alpha 1 (HPA043673) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The BPI fold containing family A, member 2 (HPA044006) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The lactate dehydrogenase C (HPA045442) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The gastrokine 1 (HPA047684) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The testis specific protein, Y-linked 1, testis specific protein, Y-linked 2, testis specific protein, Y-linked 3, testis specific protein, Y-linked 4, testis specific protein, Y-linked 6, pseudogene, testis specific protein, Y-linked 8, testis specific protein, Y-linked 10 stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The insulin-like 5 (HPA030100 & CAB033849) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The actin-related protein T2 (HPA006480) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The phospholipase C, beta 3 (phosphatidylinositol-specific) (CAB009257) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The leucine rich repeat containing 38 (HPA038778) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The defensin, alpha 5, Paneth cell-specific (HPA015775) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The chromosome 1 open reading frame 170 (HPA031711) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The transglutaminase 3 (HPA004728) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The isthmin 2 (HPA039314) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The actin-related protein T3 (HPA035817) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The secretagogin, EF-hand calcium binding protein (HPA006641) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The interleukin 1 receptor antagonist (CAB009633) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The caspase 14, apoptosis-related cysteine peptidase (CAB010059) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The diffuse panbronchiolitis critical region 1 (HPA014036) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The proteasome (prosome, macropain) subunit, beta type, 9 (CAB015180) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The doublecortin-like kinase 2 (HPA015770) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The G protein-coupled receptor 17 (HPA029766) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The cytochrome P450, family 17, subfamily A, polypeptide 1 stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The low density lipoprotein receptor class A domain containing 1 (HPA052489) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The endoplasmic reticulum protein 27 (HPA039636) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The ArfGAP with FG repeats 2 (HPA019689) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The emerin (HPA000609) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The fms-related tyrosine kinase 1 (HPA014290 & HPA011740) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The POU class 2 homeobox 3 (HPA019652) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The growth differentiation factor 2 (CAB023357) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The isocitrate dehydrogenase 1 (NADP+), soluble (HPA035248) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The erythrocyte membrane protein band 4.2 (HPA040261) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The hyaluronan and proteoglycan link protein 2 (HPA045765) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The myosin, light chain 7, regulatory (HPA013331) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The family with sequence similarity 92, member B (HPA041022) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The retinol dehydrogenase 11 (all-trans/9-cis/11-cis) (CAB046011) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The leiomodin 2 (cardiac) (HPA051039) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The tumor protein p73 (CAB002514) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The annexin A10 (HPA005469) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The MORC family CW-type zinc finger 4 antibody (HPA001017) has been omitted and replaced by another antibody (HPA000395) originated from identical PrEST since HPA000395 shows a more distinct staining pattern.
• The CAB020711 antibody has been omitted due to target gene not found in Ensembl.
• The HPA056305 antibody has been omitted due to target gene not found in Ensembl.
• The HPA048324 antibody has been omitted due to target gene not found in Ensembl.
• The HPA053500 antibody has been omitted due to target gene not found in Ensembl.
• The HPA052039 antibody has been omitted due to target gene not found in Ensembl.
• The HPA047665 antibody has been omitted due to target gene not found in Ensembl.
• The HPA047717 antibody has been omitted due to target gene not found in Ensembl.
• The HPA047525 antibody has been omitted due to target gene not found in Ensembl.
• The HPA045742 antibody has been omitted due to target gene not found in Ensembl.
• The HPA046349 antibody has been omitted due to target gene not found in Ensembl.
• The HPA048897 antibody has been omitted due to target gene not found in Ensembl.
• The HPA045040 antibody has been omitted due to target gene not found in Ensembl.
• The HPA043677 antibody has been omitted due to target gene not found in Ensembl.
• The HPA045315 antibody has been omitted due to target gene not found in Ensembl.
• The HPA043842 antibody has been omitted due to target gene not found in Ensembl.
• The HPA045953 antibody has been omitted due to target gene not found in Ensembl.
• The HPA045048 antibody has been omitted due to target gene not found in Ensembl.
• The HPA053779 antibody has been omitted due to target gene not found in Ensembl.
• The HPA045443 antibody has been omitted due to target gene not found in Ensembl.
• The HPA046401 antibody has been omitted due to target gene not found in Ensembl.
• The HPA050866 antibody has been omitted due to target gene not found in Ensembl.
• The HPA043695 antibody has been omitted due to target gene not found in Ensembl.
• The HPA045630 antibody has been omitted due to target gene not found in Ensembl.
• The HPA044973 antibody has been omitted due to target gene not found in Ensembl.
• The HPA043101 antibody has been omitted due to target gene not found in Ensembl.
• The HPA042624 antibody has been omitted due to target gene not found in Ensembl.
• The HPA044018 antibody has been omitted due to target gene not found in Ensembl.
• The HPA047711 antibody has been omitted due to target gene not found in Ensembl.
• The HPA052349 antibody has been omitted due to target gene not found in Ensembl.
• The HPA042724 antibody has been omitted due to target gene not found in Ensembl.
• The HPA042693 antibody has been omitted due to target gene not found in Ensembl.
• The HPA047391 antibody has been omitted due to target gene not found in Ensembl.
• The HPA042086 antibody has been omitted due to target gene not found in Ensembl.
• The HPA043291 antibody has been omitted due to target gene not found in Ensembl.
• The HPA042104 antibody has been omitted due to target gene not found in Ensembl.
• The HPA038365 antibody has been omitted due to target gene not found in Ensembl.
• The HPA037405 antibody has been omitted due to target gene not found in Ensembl.
• The HPA041389 antibody has been omitted due to target gene not found in Ensembl.
• The HPA039604 antibody has been omitted due to target gene not found in Ensembl.
• The HPA036454 antibody has been omitted due to target gene not found in Ensembl.
• The HPA044091 antibody has been omitted due to target gene not found in Ensembl.
• The HPA036644 antibody has been omitted due to target gene not found in Ensembl.
• The HPA047689 antibody has been omitted due to target gene not found in Ensembl.
• The HPA037610 antibody has been omitted due to target gene not found in Ensembl.
• The HPA030240 antibody has been omitted due to target gene not found in Ensembl.
• The HPA030157 antibody has been omitted due to target gene not found in Ensembl.
• The HPA027116 antibody has been omitted due to target gene not found in Ensembl.
• The HPA022857 antibody has been omitted due to target gene not found in Ensembl.
• The HPA023055 antibody has been omitted due to target gene not found in Ensembl.
• The HPA022890 antibody has been omitted due to target gene not found in Ensembl.
• The HPA044320 antibody has been omitted due to target gene not found in Ensembl.
• The HPA042423 antibody has been omitted due to target gene not found in Ensembl.
• The HPA016895 antibody has been omitted due to target gene not found in Ensembl.
• The HPA016715 antibody has been omitted due to target gene not found in Ensembl.
• The HPA012541 antibody has been omitted due to target gene not found in Ensembl.
• The HPA030441 antibody has been omitted due to target gene not found in Ensembl.

Protein Atlas version 11 - 2013.03.11

• Eleventh major release of the Human Protein Atlas with more than 18,000 antibodies, targeting proteins from more than 15,000 human genes (~75% of the human protein-coding genes).
• Protein evidence for all 20.083 predicted genes based on manual annotation from literature (UniProt), antibody-based profiling in cells, tissues and organs and analysis of transcripts using next generation sequencing.
• Eight new cell lines: A-549, CACO-2, HEK 293, HeLA, Hep-G2, MCF-7, PC-3 and RT-4, have been analyzed in the RNAseq assay.
• Neuropil (in cerebral cortex) has been annotated and added in the normal tissue immunohistochemistry assay.
• The guanine nucleotide binding protein (G protein), beta polypeptide 3 antibody (HPA005645) has been omitted due to nuclear positivity.
• The protocadherin 19 antibody (HPA001461) has been omitted due to lack of membranous positivity.
• The SAM domain and HD domain 1 antibody (CAB002004) has been omitted due to lack of nuclear positivity. An alternative antibody (HPA047072) showing nuclear positivity has been added.
• The orthodenticle homeobox 1 antibody (CAB012341) has been omitted due to lack of positivity in brain. An alternative antibody (HPA052122) showing positivity in brain has been added.
• The interleukin 1, alpha antibody (CAB004449) has been omitted due to lack of secreted staining.
• The TNF receptor-associated protein 1 antibody (CAB004281) has been omitted due to lack of general granular positivity. Alternative antibodies (HPA041082 & HPA044227) showing general granular positivity have been added.
• The protease, serine, 57 antibody (HPA006099) has been omitted due to disconcordant staining.
• The ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 antibody (CAB002310) has been omitted since it has been discontinued by the commercial distributor. An alternative antibody (CAB032706) targeting the same gene has been added.
• The chromogranin A (parathyroid secretory protein 1) antibody (CAB000023) has been omitted since it has been discontinued by the commercial distributor. An alternative antibody (CAB055506) targeting the same gene has been added.
• The regulatory factor X, 6 antibody (HPA037697) has been omitted due to lack of positivity in endocrine pancreas. An alternative antibody (HPA037696) showing positivity in endocrine pancreas has been added.
• The KRIT1, ankyrin repeat containing antibody (HPA022155) has been omitted due to lack of positivity in endothelial cells. An alternative antibody (HPA049606) showing positivity in endothelial cells has been added.
• The BCL2-related protein A1 antibody (CAB010382) has been omitted due to lack of positivity in lymphoid tissues.
• The dipeptidyl-peptidase 6 antibody (CAB025851) has been omitted due to lack of positivity in brain. An alternative antibody (HPA050509) showing positivity in brain has been added.
• The adiponectin receptor 1 antibody (CAB015935) has been omitted due to lack of plasma membrane positivity.
• The structural maintenance of chromosomes 4 antibody (HPA018259) has been omitted due to a selective staining pattern when it should stain ubiquitous. An alternative antibody (CAB055509) showing general positivity has been added.
• The cytochrome c oxidase subunit VIa polypeptide 2 antibody (HPA044591) has been omitted due to lack of mitochondrial positivity.
• The nuclear receptor subfamily 2, group C, member 1 antibody (CAB010395) has been omitted due to lack of nuclear positivity.
• The suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein) antibody (CAB017443) has been omitted due to nuclear staining. Alternative antibodies (HPA043233, HPA046412, HPA047114 & HPA047116) showing cytoplasmic positivity have been added
• The somatostatin receptor 5 antibody (CAB005615) has been omitted due to nuclear positivity.
• The discoidin domain receptor tyrosine kinase 2 antibody (CAB010432) has been omitted due to a selective staining pattern when it should stain more general.
• The hydroxysteroid (11-beta) dehydrogenase 1 antibody (CAB003788) has been omitted due to low positivity in liver compared to many other tissues. An alternative antibody (HPA047729) showing strong positivity in liver has been added.
• The chemokine (C-X-C motif) receptor 1 antibody (CAB016267) has been omitted due to lack of positivity in neutrophils.
• The thyroid hormone receptor interactor 10 antibody (CAB035547) has been omitted due to a selective staining pattern when it should stain ubiquitous.
• The solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 antibody (CAB009393) has been omitted due to lack of positivity in lymphoid tissues.
• The activin A receptor, type IB antibody (CAB026126) has been omitted due to lack of membranous positivity.
• The acetylserotonin O-methyltransferase-like antibody (HPA021865) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The kallikrein-related peptidase 7 antibody (HPA018994) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The profilin 1 antibody (CAB037140) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The 2',3'-cyclic nucleotide 3' phosphodiesterase antibodies (HPA023278, HPA023280 and HPA023338) stained images have been omitted and replaced with images from a more recent staining with the same antibodies.
• The dickkopf-like 1 antibody (CAB025410) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The ELAV (embryonic lethal, abnormal vision, Drosophila)-like 3 (Hu antigen C) antibody (CAB013066) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The Rac GTPase activating protein 1 antibody (CAB025859) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The guanine nucleotide binding protein (G protein), q polypeptide antibody (CAB010036) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The myosin, light chain 12A, regulatory, non-sarcomeric antibody (CAB004503) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The charged multivesicular body protein 5 antibody (CAB033874) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The developmental pluripotency associated 4 antibody (CAB020678) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The derlin 2 antibody (CAB037287) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The sialidase 2 (cytosolic sialidase) antibody (CAB022336) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The dopey family member 2 antibody (CAB034922) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The testis expressed 33 antibody (HPA005998) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The lipase, hormone-sensitive antibody (CAB017700) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The glycoprotein (transmembrane) nmb antibody (CAB026224) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The retinoblastoma binding protein 6 antibody (CAB032866) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The tenomodulin antibody (HPA034961) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The stromal cell derived factor 4 antibody (CAB015227) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The myomesin (M-protein) 2, 165kDa antibody (HPA005953) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The methylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria antibody (HPA027394) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The mediator complex subunit 19 antibodies (HPA039912 and HPA040860) stained images have been omitted and replaced with images from a more recent staining with the same antibodies.
• The melanoma associated antigen (mutated) 1-like 1 antibodies (HPA020464 and HPA000168) stained images have been omitted and replaced with images from a more recent staining with the same antibodies.
• The coiled-coil domain containing 144A antibody (HPA022996) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The cathelicidin antimicrobial peptide antibodies (CAB015949 and CAB016522) stained images have been omitted and replaced with images from a more recent staining with the same antibodies.
• The dopamine receptor D2 antibody (HPA015691) stained images have been omitted and replaced with images from a more recent staining with the same antibodies.
• The kinesin family member 1C antibody (HPA021831) has been omitted due to overlapping antigen with antibody HPA045020 targeting the same gene (disagreement with the concept of independent antibodies for quality assurance).
• The CAB004518 antibody has been omitted due to target gene not found in Ensembl.
• The CAB005592 antibody has been omitted due to target gene not found in Ensembl.
• The CAB034205 antibody has been omitted due to target gene not found in Ensembl.
• The HPA003446 antibody has been omitted due to target gene not found in Ensembl.
• The HPA019858 antibody has been omitted due to target gene not found in Ensembl.
• The HPA021630 antibody has been omitted due to target gene not found in Ensembl.
• The HPA022139 antibody has been omitted due to target gene not found in Ensembl.
• The HPA023076 antibody has been omitted due to target gene not found in Ensembl.
• The HPA023495 antibody has been omitted due to target gene not found in Ensembl.
• The HPA023862 antibody has been omitted due to target gene not found in Ensembl.
• The HPA023908 antibody has been omitted due to target gene not found in Ensembl.
• The HPA024416 antibody has been omitted due to target gene not found in Ensembl.
• The HPA024633 antibody has been omitted due to target gene not found in Ensembl.
• The HPA025700 antibody has been omitted due to target gene not found in Ensembl.
• The HPA027269 antibody has been omitted due to target gene not found in Ensembl.
• The HPA027270 antibody has been omitted due to target gene not found in Ensembl.
• The HPA029425 antibody has been omitted due to target gene not found in Ensembl.
• The HPA035687 antibody has been omitted due to target gene not found in Ensembl.
• The HPA036919 antibody has been omitted due to target gene not found in Ensembl.
• The HPA038358 antibody has been omitted due to target gene not found in Ensembl.
• The HPA038835 antibody has been omitted due to target gene not found in Ensembl.
• The HPA039741 antibody has been omitted due to target gene not found in Ensembl.
• The HPA041046 antibody has been omitted due to target gene not found in Ensembl.
• The HPA041864 antibody has been omitted due to target gene not found in Ensembl.
• The HPA043465 antibody has been omitted due to target gene not found in Ensembl.
• The HPA043733 antibody has been omitted due to target gene not found in Ensembl.
• The HPA043776 antibody has been omitted due to target gene not found in Ensembl.
• The HPA044027 antibody has been omitted due to target gene not found in Ensembl.
• The HPA044152 antibody has been omitted due to target gene not found in Ensembl.
• The HPA044162 antibody has been omitted due to target gene not found in Ensembl.
• The HPA044381 antibody has been omitted due to target gene not found in Ensembl.
• The HPA044447 antibody has been omitted due to target gene not found in Ensembl.
• The HPA045320 antibody has been omitted due to target gene not found in Ensembl.
• The HPA045533 antibody has been omitted due to target gene not found in Ensembl.
• The HPA045566 antibody has been omitted due to target gene not found in Ensembl.
• The HPA047080 antibody has been omitted due to target gene not found in Ensembl.
• The HPA047197 antibody has been omitted due to target gene not found in Ensembl.
• The HPA047528 antibody has been omitted due to target gene not found in Ensembl.
• The HPA048357 antibody has been omitted due to target gene not found in Ensembl.
• The HPA048611 antibody has been omitted due to target gene not found in Ensembl.
• The HPA049408 antibody has been omitted due to target gene not found in Ensembl.
• The HPA049804 antibody has been omitted due to target gene not found in Ensembl.
• The HPA051106 antibody has been omitted due to target gene not found in Ensembl.
• The HPA051139 antibody has been omitted due to target gene not found in Ensembl.
• The HPA052092 antibody has been omitted due to target gene not found in Ensembl.

Protein Atlas version 10 - 2012.09.12

• Tenth major release of the Human Protein Atlas with more than 17,000 antibodies, targeting proteins from more than 14,000 human genes (~70% of the human protein-coding genes).
• The chromatin assembly factor 1, subunit B (p60) antibodies (HPA016698 and HPA029538) have been omitted due to cytoplasmic positivity and lack of nuclear staining. An alternative antibody (CAB033604) showing nuclear staining in dividing cells has been added.
• The purinergic receptor P2X, ligand-gated ion channel, 7 antibody (HPA034967) has been omitted due to a selective staining pattern.
• The heat shock 27 kDa protein 1 antibody (CAB002061) has been omitted due to a selective staining pattern. HPA000497, CAB004439 and CAB047331 show a more general staining pattern.
• The heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) antibody (CAB019420) has been omitted due to a selective staining pattern. HPA038845, HPA038846 and CAB005221 show a general staining pattern.
• The Cbl proto-oncogene, E3 ubiquitin protein ligase B antibody (HPA016864) has been omitted due to nuclear staining. HPA018327 and HPA019880 show cytoplasmic staining.
• The BCL2-like 2 antibody (CAB002048) has been omitted due to a selective staining pattern. CAB040539 shows a general staining pattern.
• The chloride intracellular channel 1 antibody (HPA008917) has been omitted due to unspecific staining. CAB020825 and CAB040557 show a more reliable staining pattern.
• The insulin receptor antibody (CAB013113) has been omitted due to lack of staining in liver and muscle.
• The cytochrome P450, family 7, subfamily A, polypeptide 1 antibody (HPA010970) has been omitted due to lack of staining in liver.
• The 24-dehydrocholesterol reductase antibody (HPA028826) has been omitted due to lack of staining in liver. An alternative antibody (CAB037247) showing positivity in liver has been added.
• The phosphoinositide-3-kinase, catalytic, gamma polypeptide antibody (CAB010283) has been omitted due to nuclear staining.
• The vitamin D (1,25- dihydroxyvitamin D3) receptor antibody (CAB004617) has been omitted due to cytoplasmic staining.
• The G elongation factor, mitochondrial 2 antibody (HPA036864) has been omitted due to lack of staining in liver. An alternative antibody (HPA036863) showing positivity in liver has been added.
• The bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase) antibody (HPA021251) has been omitted due to lack of staining in liver. An alternative antibody (HPA021330) showing positivity in liver has been added.
• The caspase 8, apoptosis-related cysteine peptidase antibody (HPA008936) has been omitted due to a selective staining pattern. HPA001302, CAB002047 and HPA005688 show a more general staining pattern.
• The latent-transforming growth factor beta-binding protein 1 antibody (HPA005707) has been omitted due to lack of extracellular staining. CAB025428 shows extracellular positivity.
• The geminin, DNA replication inhibitor antibody (CAB047328) has been omitted due to a general nuclear staining pattern when it should only stain proliferating cells. An alternative antibody (CAB047327) showing nuclear positivity in dividing cells has been added.
• The serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 antibody (CAB002516) has been omitted due to lack of extracellular staining or staining of endothelial cells. An alternative antibody (HPA050039) showing positivity in endothelial cells has been added.
• The NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9, 39kDa antibody (CAB034893) has been omitted due to selective staining. An alternative antibody (HPA042268) showing a general staining pattern has been added.
• The aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alphahydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4) antibody (CAB006258) has been omitted due to a general staining pattern when it should be liver specific. An alternative antibody (HPA044720) showing a more selective staining and positivity in liver has been added.
• The pyruvate kinase, liver and RBC antibody (HPA011991) has been omitted due to lack of positivity in liver. Alternative antibodies (CAB034376 and CAB034378) showing positivity in liver have been added.
• The myostatin antibodies (HPA018534 and HPA021681) have been omitted due to lack of extracellular positivity. CAB009963 shows extracellular positivity.
• The TYRO3 protein tyrosine kinase antibody (HPA007654) has been omitted due to lack of cell membranous positivity.
• The neuregulin 1 antibody (CAB002304) has been omitted since it has been discontinued by the commercial distributor.
• The mucin 16, cell surface associated antibody (CAB000004) has been omitted since it has been discontinued by the commercial distributor. An alternative antibody (CAB055170) targeting the same gene has been added.
• The KIAA2022 antibody (HPA000404) has been been omitted and replaced by another antibody (HPA000407) originating from identical PrEST since HPA000407 shows a more distinct staining pattern.
• The troponin T type 3 (skeletal, fast) antibody (CAB000472) has been been omitted due to overlapping antigen with antibody CAB002451 targeting the same gene (disagreement with the concept of independent antibodies for quality assurance).
• The mitochondrial ribosomal protein L40 antibody (CAB010069) has been omitted since it has been discontinued by the commercial distributor. The antibody HPA006181 targeting the same gene has been added.
• The PHD finger protein 20 antibody (HPA029620) has been omitted due to cytoplasmic positivity and lack of nuclear staining. HPA029619 shows nuclear positivity.
• The terminal uridylyl transferase 1, U6 snRNA-specific antibody (CAB004969) has been omitted due to cytoplasmic positivity and lack of nuclear staining.
• The fms-related tyrosine kinase 4 antibody (CAB000099) has been omitted due to lack of positivity in vessels.
• The adenylate kinase 1 antibody (HPA006456) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The moesin antibody (CAB047338) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The 8-oxoguanine DNA glycosylase antibody (CAB047301) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The WW domain containing transcription regulator 1 antibody (CAB017483) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The chromosome X open reading frame 57 antibody (HPA000896) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The carbonic anhydrase IX antibody (CAB005100) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The Insulin antibody (HPA004932) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The serine/threonine kinase 4 antibody (HPA015270) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The oligodendrocyte myelin glycoprotein antibodies (HPA008206 and HPA012693) stained images have been omitted and replaced with images from a more recent staining with the same antibodies.
• The ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D antibody (HPA031515) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The Chloride intracellular channel protein 1 antibodies (CAB020825 and CAB040557) stained images have been omitted and replaced with images from a more recent staining with the same antibodies.
• The HEAT repeat containing 4 antibodies (HPA003642 and HPA019767) stained images have been omitted and replaced with images from a more recent staining with the same antibodies.
• The keratin 83 antibody (CAB004987) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The membrane protein, palmitoylated 6 (MAGUK p55 subfamily member 6) antibodies (HPA020456 and HPA019085) stained images have been omitted and replaced with images from more recent stainings with the same antibodies.
• The small proline-rich protein 1A antibody (CAB011237) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The ankyrin repeat and SOCS box containing 1 antibody (HPA003508) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The chordin-like 1 antibody (HPA000250) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The scinderin antibody (HPA020518) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The CAB008594 antibody has been omitted due to target gene not found in Ensembl.
• The HPA041886 antibody has been omitted due to target gene not found in Ensembl.
• The HPA040799 antibody has been omitted due to target gene not found in Ensembl.
• The HPA041926 antibody has been omitted due to target gene not found in Ensembl.
• The HPA042108 antibody has been omitted due to target gene not found in Ensembl.
• The HPA028677 antibody has been omitted due to target gene not found in Ensembl.
• The HPA010786 antibody has been omitted due to target gene not found in Ensembl.
• The HPA019112 antibody has been omitted due to target gene not found in Ensembl.
• The HPA022521 antibody has been omitted due to target gene not found in Ensembl.
• The HPA043690 antibody has been omitted due to target gene not found in Ensembl.
• The HPA045651 antibody has been omitted due to target gene not found in Ensembl.
• The HPA041320 antibody has been omitted due to target gene not found in Ensembl.
• The HPA041181 antibody has been omitted due to target gene not found in Ensembl.
• The HPA041526 antibody has been omitted due to target gene not found in Ensembl.
• The HPA009028 antibody has been omitted due to target gene not found in Ensembl.
• The HPA017993 antibody has been omitted due to target gene not found in Ensembl.
• The HPA027338 antibody has been omitted due to target gene not found in Ensembl.
• The HPA042153 antibody has been omitted due to target gene not found in Ensembl.

Protein Atlas version 9 - 2011.11.11

• Ninth major release of the Human Protein Atlas with more than 15,500 antibodies, targeting proteins from more than 12,200 human genes (~61% of the human protein-coding genes).
• The DNA-damage-inducible transcript 3 antibody (CAB008969) has been omitted due to unspecific staining.
• The chromosome 1 open reading frame 222 antibody (HPA028491) has been omitted due to nuclear staining.
• The ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1 antibody (HPA024243) has been omitted due to indistinct staining.
• The ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1 antibody (CAB009525) has been omitted due to nuclear staining.
• The S100 calcium binding protein A4 antibody (CAB027387) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The S100 calcium binding protein A4 antibody (HPA007973) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The YY1 associated protein 1 antibody (HPA006986) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The tropomyosin 1 (alpha) antibody (CAB017698) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The solute carrier family 7 (cationic amino acid transporter, y+ system), member 9 antibody (HPA042591) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa) antibody (CAB002682) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The choroideremia (Rab escort protein 1) antibody (CAB016171) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The gamma-aminobutyric acid (GABA) A receptor, alpha 1 antibody (CAB022502) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The insulin-like growth factor binding protein 7 antibody (HPA002196) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The kinesin family member 7 antibody (HPA043145) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The RAD23 homolog B antibody (HPA029719) has been omitted due to a staining pattern deviating from that of the sibling antibodies.
• The keratin 18 antibody (CAB000092) has been omitted due to specific staining of caspase cleaved keratin 18.
• The glutathione S-transferase mu 1 antibody (CAB027393) has been omitted due to addition of an alternative and more specific antibody to the Protein Atlas.
• The HPA000519 antibody has been omitted due to target gene not found in Ensembl.
• The HPA003232 antibody has been omitted due to target gene not found in Ensembl.
• The HPA003553 antibody has been omitted due to target gene not found in Ensembl.
• The HPA003644 antibody has been omitted due to target gene not found in Ensembl.
• The CAB010396 antibody has been omitted due to target gene not found in Ensembl.
• The HPA014347 antibody has been omitted due to target gene not found in Ensembl.
• The HPA014850 antibody has been omitted due to target gene not found in Ensembl.
• The HPA018452 antibody has been omitted due to target gene not found in Ensembl.
• The HPA023262 antibody has been omitted due to target gene not found in Ensembl.
• The CAB025805 antibody has been omitted due to target gene not found in Ensembl.
• The HPA025821 antibody has been omitted due to target gene not found in Ensembl.
• The HPA026562 antibody has been omitted due to target gene not found in Ensembl.
• The HPA027480 antibody has been omitted due to target gene not found in Ensembl.
• The HPA028260 antibody has been omitted due to target gene not found in Ensembl.
• The HPA030710 antibody has been omitted due to target gene not found in Ensembl.
• The HPA030809 antibody has been omitted due to target gene not found in Ensembl.
• The HPA030810 antibody has been omitted due to target gene not found in Ensembl.
• The CAB033804 antibody has been omitted due to target gene not found in Ensembl.
• The HPA038584 antibody has been omitted due to target gene not found in Ensembl.
• The HPA039525 antibody has been omitted due to target gene not found in Ensembl.
• The HPA040714 antibody has been omitted due to target gene not found in Ensembl.
• The HPA041033 antibody has been omitted due to target gene not found in Ensembl.
• The HPA041543 antibody has been omitted due to target gene not found in Ensembl.
• The HPA041980 antibody has been omitted due to target gene not found in Ensembl.
• The HPA042002 antibody has been omitted due to target gene not found in Ensembl.
• The HPA043385 antibody has been omitted due to target gene not found in Ensembl.

Protein Atlas version 8 - 2011.05.16

• Eigth major release of the Human Protein Atlas with more than 14,500 antibodies, targeting proteins from more than 11,250 human genes (~56% of the human protein-coding genes).
• The transcription factor 21, TCF21 antibody (HPA012792) has been omitted due to publication of two antibodies produced against the same PrEST.
• The tumor necrosis factor (ligand) superfamily, member 14 antibody (HPA026919) has been omitted due to publication of two antibodies produced against the same PrEST.
• The surfactant protein C antibody (HPA011644) has been omitted due to publication of two antibodies produced against the same PrEST.
• The family with sequence similarity 26, member D antibody (HPA014524) has been omitted due to publication of two antibodies produced against the same PrEST.
• The glial fibrillary acidic protein antibody (CAB000039) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The amylase, alpha 1A (salivary) antibody (CAB004310) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The tripartite motif containing 22 antibody (HPA003575) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The BCDIN3 domain containing protein antibody (HPA039911) stained images have been omitted and replaced with images from a more recent scanning of the same stained TMA slides.
• The pleiomorphic adenoma gene 1 antibody (HPA005462) has been omitted due to lack of nuclear staining.
• The SH2 domain containing 2A, SH2D2A antibody (HPA019483) has been omitted due to lack of staining in T cells.
• The Fas ligand (TNF superfamily, member 6) antibody (HPA030524) has been omitted due to lack of staining in T and NK cells.
• The signal transducer and activator of transcription 6, interleukin-4 induced, STAT6 antibody (CAB002613) has been omitted due to lack of nuclear staining.
• The calcium channel, voltage-dependent, L type, alpha 1D subunit, CACNA1D antibody (CAB009777) has been omitted due to nuclear staining.
• The potassium inwardly-rectifying channel, subfamily J member 10, KCNJ10 antibody (HPA011992) has been omitted due to nuclear membrane staining.
• The interleukin 1 receptor, type I, IL1R1 antibody (HPA029559) has been omitted due to nucleolar staining.
• The Kv channel interacting protein 3, calsenilin, KCNIP3 antibody (CAB010450) has been omitted due to lack of staining in the CNS.
• The crystallin, zeta (quinone reductase), CRYZ, antibody (HPA021919) has been omitted due to overlapping antigen with other antibody targeting the same gene.
• The pumilio homolog 1 (Drosophila), PUM1, antibody (HPA027430) has been omitted due to overlapping antigen with other antibody targeting the same gene.
• The protein prenyltransferase alpha subunit repeat containing 1, PTAR1, antibody (HPA022781) has been omitted due to overlapping antigen with other antibody targeting the same gene.
• The transketolase-like 1, TKTL1, antibody (HPA029155) has been omitted due to overlapping antigen with other antibody targeting the same gene.
• The secreted phosphoprotein 1, SPP1, antibody (HPA027540) has been omitted due to overlapping antigen with other antibody targeting the same gene.
• The PTK2 protein tyrosine kinase 2, PTK2, antibody (HPA029671) has been omitted due to overlapping antigen with other antibody targeting the same gene.
• The ring finger protein 24, RNF24, antibody (HPA036637) has been omitted due to overlapping antigen with other antibody targeting the same gene.
• The aspartyl-tRNA synthetase, DARS, antibody (HPA024079) has been omitted due to overlapping antigen with other antibody targeting the same gene.
• The filaggrin, FLG, antibody (HPA027505) has been omitted due to overlapping antigen with other antibody targeting the same gene.
• The SKI-like oncogene, SKIL, antibody (HPA013920) has been omitted due to overlapping antigen with other antibody targeting the same gene.
• The CAB010763 antibody has been omitted due to target gene not found in Ensembl.
• The CAB017481 antibody has been omitted due to target gene not found in Ensembl.
• The CAB017800 antibody has been omitted due to target gene not found in Ensembl.
• The CAB020836 antibody has been omitted due to target gene not found in Ensembl.
• The HPA001187 antibody has been omitted due to target gene not found in Ensembl.
• The HPA011085 antibody has been omitted due to target gene not found in Ensembl.
• The HPA012131 antibody has been omitted due to target gene not found in Ensembl.
• The HPA012167 antibody has been omitted due to target gene not found in Ensembl.
• The HPA013202 antibody has been omitted due to target gene not found in Ensembl.
• The HPA014078 antibody has been omitted due to target gene not found in Ensembl.
• The HPA014103 antibody has been omitted due to target gene not found in Ensembl.
• The HPA014441 antibody has been omitted due to target gene not found in Ensembl.
• The HPA014911 antibody has been omitted due to target gene not found in Ensembl.
• The HPA015527 antibody has been omitted due to target gene not found in Ensembl.
• The HPA015978 antibody has been omitted due to target gene not found in Ensembl.
• The HPA016828 antibody has been omitted due to target gene not found in Ensembl.
• The HPA017431 antibody has been omitted due to target gene not found in Ensembl.
• The HPA017725 antibody has been omitted due to target gene not found in Ensembl.
• The HPA019155 antibody has been omitted due to target gene not found in Ensembl.
• The HPA021040 antibody has been omitted due to target gene not found in Ensembl.
• The HPA021078 antibody has been omitted due to target gene not found in Ensembl.
• The HPA021544 antibody has been omitted due to target gene not found in Ensembl.
• The HPA021644 antibody has been omitted due to target gene not found in Ensembl.
• The HPA021847 antibody has been omitted due to target gene not found in Ensembl.
• The HPA024095 antibody has been omitted due to target gene not found in Ensembl.
• The HPA024257 antibody has been omitted due to target gene not found in Ensembl.
• The HPA025759 antibody has been omitted due to target gene not found in Ensembl.
• The HPA026879 antibody has been omitted due to target gene not found in Ensembl.
• The HPA027059 antibody has been omitted due to target gene not found in Ensembl.
• The HPA027313 antibody has been omitted due to target gene not found in Ensembl.
• The HPA027324 antibody has been omitted due to target gene not found in Ensembl.
• The HPA027561 antibody has been omitted due to target gene not found in Ensembl.
• The HPA027571 antibody has been omitted due to target gene not found in Ensembl.
• The HPA027633 antibody has been omitted due to target gene not found in Ensembl.
• The HPA027828 antibody has been omitted due to target gene not found in Ensembl.
• The HPA027953 antibody has been omitted due to target gene not found in Ensembl.
• The HPA028902 antibody has been omitted due to target gene not found in Ensembl.
• The HPA029050 antibody has been omitted due to target gene not found in Ensembl.
• The HPA029512 antibody has been omitted due to target gene not found in Ensembl.
• The HPA030365 antibody has been omitted due to target gene not found in Ensembl.
• The HPA030366 antibody has been omitted due to target gene not found in Ensembl.
• The HPA030597 antibody has been omitted due to target gene not found in Ensembl.
• The HPA034601 antibody has been omitted due to target gene not found in Ensembl.
• The HPA035579 antibody has been omitted due to target gene not found in Ensembl.
• The HPA035673 antibody has been omitted due to target gene not found in Ensembl.
• The HPA036477 antibody has been omitted due to target gene not found in Ensembl.
• The HPA036625 antibody has been omitted due to target gene not found in Ensembl.
• The HPA036666 antibody has been omitted due to target gene not found in Ensembl.
• The HPA036673 antibody has been omitted due to target gene not found in Ensembl.
• The HPA037887 antibody has been omitted due to target gene not found in Ensembl.
• The HPA038210 antibody has been omitted due to target gene not found in Ensembl.
• The HPA038365 antibody has been omitted due to target gene not found in Ensembl.
• The HPA038651 antibody has been omitted due to target gene not found in Ensembl.
• The HPA039020 antibody has been omitted due to target gene not found in Ensembl.
• The HPA039142 antibody has been omitted due to target gene not found in Ensembl.
• The HPA039524 antibody has been omitted due to target gene not found in Ensembl.
• The HPA039666 antibody has been omitted due to target gene not found in Ensembl.
• The HPA040085 antibody has been omitted due to target gene not found in Ensembl.
• The HPA040334 antibody has been omitted due to target gene not found in Ensembl.

Protein Atlas version 7.1 - 2011.01.14

• Erroneous RNA RPKM values for 944 genes (listed here) have been corrected.
• The annotated protein expression values (IH) for MLLT4 (ENSG00000130396) and NR3C1 (ENSG00000113580) have been updated.

Protein Atlas version 7 - 2010.11.15

• Seventh major release of the Human Protein Atlas with more than 13,150 antibodies, targeting proteins from more than 10,100 human genes (~50% of the human protein-coding genes).
• Major redesign of the Human Protein Atlas web portal.
• Knowledge-based annotated protein expression added.
• The ras-related C3 botulinum toxin substrate 1 antibody (CAB002002) has been omitted due to nuclear staining. An alternative antibody (CAB035994) showing cytoplasmic staining has been added.
• The TAF9 RNA polymerase II, TATA box binding protein (TBP)-associated factor antibody (HPA031968) has been omitted due to ubiquitous cytoplasmic staining.
• The serine/threonine kinase 4 antibody (CAB004965) has been omitted due to staining mainly in goblet cells.
• The nitric oxide synthase 1 (neuronal) adaptor protein antibody (HPA027712) has been omitted due to ubiquitous nuclear staining.
• The RPA interacting protein antibody (HPA022478) has been omitted due to technical difficulties.
• The egl nine homolog 2 antibody (HPA001624) has been omitted due to technical difficulties.
• The CAB009738 antibody has been omitted due to target gene not found in Ensembl.
• The CAB022461 antibody has been omitted due to target gene not found in Ensembl.
• The CAB034119 antibody has been omitted due to target gene not found in Ensembl.
• The HPA001206 antibody has been omitted due to target gene not found in Ensembl.
• The HPA003181 antibody has been omitted due to target gene not found in Ensembl.
• The HPA003209 antibody has been omitted due to target gene not found in Ensembl.
• The HPA003285 antibody has been omitted due to target gene not found in Ensembl.
• The HPA003550 antibody has been omitted due to target gene not found in Ensembl.
• The HPA004739 antibody has been omitted due to target gene not found in Ensembl.
• The HPA010516 antibody has been omitted due to target gene not found in Ensembl.
• The HPA010818 antibody has been omitted due to target gene not found in Ensembl.
• The HPA011010 antibody has been omitted due to target gene not found in Ensembl.
• The HPA011229 antibody has been omitted due to target gene not found in Ensembl.
• The HPA013760 antibody has been omitted due to target gene not found in Ensembl.
• The HPA015241 antibody has been omitted due to target gene not found in Ensembl.
• The HPA015970 antibody has been omitted due to target gene not found in Ensembl.
• The HPA017238 antibody has been omitted due to target gene not found in Ensembl.
• The HPA017595 antibody has been omitted due to target gene not found in Ensembl.
• The HPA018938 antibody has been omitted due to target gene not found in Ensembl.
• The HPA019677 antibody has been omitted due to target gene not found in Ensembl.
• The HPA019833 antibody has been omitted due to target gene not found in Ensembl.
• The HPA019856 antibody has been omitted due to target gene not found in Ensembl.
• The HPA021614 antibody has been omitted due to target gene not found in Ensembl.
• The HPA021733 antibody has been omitted due to target gene not found in Ensembl.
• The HPA023077 antibody has been omitted due to target gene not found in Ensembl.
• The HPA023156 antibody has been omitted due to target gene not found in Ensembl.
• The HPA023262 antibody has been omitted due to target gene not found in Ensembl.
• The HPA023264 antibody has been omitted due to target gene not found in Ensembl.
• The HPA023460 antibody has been omitted due to target gene not found in Ensembl.
• The HPA024025 antibody has been omitted due to target gene not found in Ensembl.
• The HPA025719 antibody has been omitted due to target gene not found in Ensembl.
• The HPA027071 antibody has been omitted due to target gene not found in Ensembl.
• The HPA027600 antibody has been omitted due to target gene not found in Ensembl.
• The HPA027912 antibody has been omitted due to target gene not found in Ensembl.
• The HPA029815 antibody has been omitted due to target gene not found in Ensembl.
• The HPA029817 antibody has been omitted due to target gene not found in Ensembl.
• The HPA030157 antibody has been omitted due to target gene not found in Ensembl.
• The HPA030375 antibody has been omitted due to target gene not found in Ensembl.
• The HPA030651 antibody has been omitted due to target gene not found in Ensembl.
• The HPA030809 antibody has been omitted due to target gene not found in Ensembl.
• The HPA030810 antibody has been omitted due to target gene not found in Ensembl.
• The HPA035002 antibody has been omitted due to target gene not found in Ensembl.

Protein Atlas version 6 - 2010.03.26

• Sixth major release of the Human Protein Atlas with more than 11,200 antibodies and more than 9,100,000 images.
• Membrane protein related protein classes have been added.
• New membrane protein topology prediction methods have been added to the protein view.
• The Two pore calcium channel protein 2 antibody (HPA0016561) has been omitted due to lack of membranous staining. An alternative antibody (HPA0027080), showing a membranous positivity, has been added to the Protein Atlas.
• The Serine/threonine-protein kinase TNNI3K antibody (HPA013188) has been omitted due to lack of staining in heart muscle.
• The Mitogen-activated protein kinase 12 antibody (HPA018841) has been omitted due to negative skeletal muscle. An alternative antibody (CAB025483), showing distinct staining in skeletal muscle, has been added to the protein atlas.
• The Thyrotropin receptor Precursor antibody (CAB000473) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The Serotonin antibody (CAB000074) has been omitted due to wrong ensg id.
• The Neurotensin receptor type 1 antibody (HPA009132) has been omitted due to nuclear positivity and lack of staining in neurons.
• The Neurexin-2-beta Precursor antibody (CAB012472) has been omitted due to ubiquitous granular cytoplasmic staining.
• The Focal adhesion kinase 1 antibody (HPA001842) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The Tumor necrosis factor receptor superfamily member 6 Precursor antibody (CAB000124) has been omitted due to weak staining. An alternative antibody (HPA027444), showing staining in inflammatory cells, has been added to the protein atlas.
• The La-related protein 7 antibody (HPA017600) has been omitted due to cytoplasmic staining. Alternative antibodies (HPA026842 and HPA027930), showing mostly nuclear staining, have been added to the protein atlas.
• The Tensin-3 antibody (HPA005547) has been omitted due to non-reliable protein expression patterns (IHC).
• The ATP-sensitive inward rectifier potassium channel 8 (CAB009504) has been omitted due to lack of membranous staining. An alternative antibody (HPA0031066), showing a membranous positivity, has been added to the Protein Atlas.
• The Pogo transposable element with KRAB domain antibody (HPA007838) has been omitted due to ubiquitous cytoplasmic and extracellular staining. An alternative antibody (HPA0031630) showing nuclear staining have been added to the protein atlas.
• The Hepatocyte cell adhesion molecule Precursor antibody (HPA0017613) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The Transketolase-like protein 1 antibody (HPA000505) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The Laminin, alpha 2 antibody (HPA005537) has been omitted due to lack of staining in basement membranes.
• The HPA000429 antibody has been omitted due to target gene not found in Ensembl.
• The HPA000523 antibody has been omitted due to target gene not found in Ensembl.
• The HPA001942 antibody has been omitted due to target gene not found in Ensembl.
• The HPA003249 antibody has been omitted due to target gene not found in Ensembl.
• The HPA003533 antibody has been omitted due to target gene not found in Ensembl.
• The HPA003535 antibody has been omitted due to target gene not found in Ensembl.
• The HPA003553 antibody has been omitted due to target gene not found in Ensembl.
• The HPA003721 antibody has been omitted due to target gene not found in Ensembl.
• The HPA004690 antibody has been omitted due to target gene not found in Ensembl.
• The HPA008331 antibody has been omitted due to target gene not found in Ensembl.
• The HPA009072 antibody has been omitted due to target gene not found in Ensembl.
• The HPA010930 antibody has been omitted due to target gene not found in Ensembl.
• The HPA011369 antibody has been omitted due to target gene not found in Ensembl.
• The HPA012133 antibody has been omitted due to target gene not found in Ensembl.
• The HPA013207 antibody has been omitted due to target gene not found in Ensembl.
• The HPA013788 antibody has been omitted due to target gene not found in Ensembl.
• The HPA014079 antibody has been omitted due to target gene not found in Ensembl.
• The HPA014207 antibody has been omitted due to target gene not found in Ensembl.
• The HPA014347 antibody has been omitted due to target gene not found in Ensembl.
• The HPA014904 antibody has been omitted due to target gene not found in Ensembl.
• The HPA014916 antibody has been omitted due to target gene not found in Ensembl.
• The HPA015796 antibody has been omitted due to target gene not found in Ensembl.
• The HPA017597 antibody has been omitted due to target gene not found in Ensembl.
• The HPA017657 antibody has been omitted due to target gene not found in Ensembl.
• The HPA018521 antibody has been omitted due to target gene not found in Ensembl.
• The HPA019064 antibody has been omitted due to target gene not found in Ensembl.
• The HPA019164 antibody has been omitted due to target gene not found in Ensembl.
• The HPA019546 antibody has been omitted due to target gene not found in Ensembl.
• The HPA020458 antibody has been omitted due to target gene not found in Ensembl.
• The HPA020854 antibody has been omitted due to target gene not found in Ensembl.
• The HPA020946 antibody has been omitted due to target gene not found in Ensembl.
• The HPA020953 antibody has been omitted due to target gene not found in Ensembl.
• The HPA021259 antibody has been omitted due to target gene not found in Ensembl.
• The HPA021268 antibody has been omitted due to target gene not found in Ensembl.
• The HPA021271 antibody has been omitted due to target gene not found in Ensembl.
• The HPA021324 antibody has been omitted due to target gene not found in Ensembl.
• The HPA021495 antibody has been omitted due to target gene not found in Ensembl.
• The HPA021642 antibody has been omitted due to target gene not found in Ensembl.
• The HPA021772 antibody has been omitted due to target gene not found in Ensembl.
• The HPA021782 antibody has been omitted due to target gene not found in Ensembl.
• The HPA022024 antibody has been omitted due to target gene not found in Ensembl.
• The HPA022247 antibody has been omitted due to target gene not found in Ensembl.
• The HPA022954 antibody has been omitted due to target gene not found in Ensembl.
• The HPA023061 antibody has been omitted due to target gene not found in Ensembl.
• The HPA023101 antibody has been omitted due to target gene not found in Ensembl.
• The HPA023105 antibody has been omitted due to target gene not found in Ensembl.
• The HPA023133 antibody has been omitted due to target gene not found in Ensembl.
• The HPA023538 antibody has been omitted due to target gene not found in Ensembl.
• The HPA023540 antibody has been omitted due to target gene not found in Ensembl.
• The HPA023931 antibody has been omitted due to target gene not found in Ensembl.
• The HPA024419 antibody has been omitted due to target gene not found in Ensembl.
• The HPA024454 antibody has been omitted due to target gene not found in Ensembl.
• The HPA024461 antibody has been omitted due to target gene not found in Ensembl.
• The HPA024799 antibody has been omitted due to target gene not found in Ensembl.
• The HPA027245 antibody has been omitted due to target gene not found in Ensembl.
• The CAB000074 antibody has been omitted due to target gene not found in Ensembl.
• The CAB000017 antibody has been omitted due to target gene not found in Ensembl.
• The CAB002774 antibody has been omitted due to target gene not found in Ensembl.
• The CAB008668 antibody has been omitted due to target gene not found in Ensembl.
• The CAB009395 antibody has been omitted due to target gene not found in Ensembl.
• The CAB016176 antibody has been omitted due to target gene not found in Ensembl.

Protein Atlas version 5 - 2009.06.16

• Fifth major release of the Human Protein Atlas with more than 8,800 antibodies and more than 7,300,000 images.
• A new protein class group, Voltage-gated ion channels, has been added.
• The Receptor tyrosine-protein kinase erbB-3 Precursor antibody (CAB000088) has been omitted due to lack of membrane positivity.
• The Ubiquitin carboxyl-terminal hydrolase 26 antibody (HPA000424) has been omitted due to general positivity.
• The Cleavage and polyadenylation specificity factor subunit 2 antibody (HPA000870) have been omitted due to cytoplasmic positivity. An alternative antibody (HPA024238), showing nuclear immunostaining pattern, has been added to the Protein Atlas.
• The Paired box protein Pax-5 antibody (CAB001449) has been removed from the protein atlas since it has been discontinued by the commercial distributor. Two alternative antibodies (CAB026269 and CAB026869) have been added to the Protein Atlas.
• The Serotonin N-acetyltransferase antibody (CAB001705) has been omitted due to general positivity.
• The Monocyte differentiation antigen CD14 antibody (HPA002127) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The Bcl-2-like protein 11 antibody (CAB002616) has been omitted due to nuclear positivity.
• The AT-rich interactive domain-containing protein 5A antibody (HPA002860) has been omitted due to cytoplasmic positivity. An alternative antibody (CAB023879), showing a nuclear immunostaining pattern, has been added to the Protein Atlas.
• The 2'-5'-oligoadenylate synthetase 2 antibody (HPA003320) has been omitted due to cytoplasmic positivity. An alternative antibody (CAB024984), showing a distinct nuclear immunostaining pattern, has been added to the Protein Atlas.
• The Runt-related transcription factor 3 antibody (HPA004195) has been omitted due to cytoplasmic positivity. An alternative antibody (CAB025416), showing a nuclear immunostaining pattern, has been added to the Protein Atlas.
• The Mitogen-activated protein kinase kinase 1-interacting protein 1 antibody (CAB004263) has been omitted due to nuclear positivity. An alternative antibody (HPA026858), showing a cytoplasmatic immunostaining pattern, has been added to the Protein Atlas.
• The Moesin antibody (CAB004505) has been omitted due to positivity in nuclear membranes.
• The Glutamate [NMDA] receptor subunit epsilon-1 Precursor antibody (HPA004692) has been omitted due to general positivity. An alternative antibody (CAB0022725), showing a more distinct immunostaining pattern in cns, has been added to the Protein Atlas.
• The Guanine nucleotide-binding protein subunit beta-2-like 1 antibody (CAB004288) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The Cardiac phospholamban antibody (CAB005597) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The Zinc finger homeobox protein 4 antibody (HPA006176) has been omitted due to cytoplasmic positivity. An alternative antibody (HPA023837), showing a nuclear immunostaining pattern, has been added to the Protein Atlas.
• The FK506-binding protein 8 antibody (HPA007054) has been omitted due to nuclear positivity. An alternative antibody (CAB025346), showing a cytoplasmic immunostaining pattern, has been added to the Protein Atlas.
• The Hepatitis A virus cellular receptor 1 Precursor antibody (HPA007173) has been omitted due to lack of positivity in T-cells.
• The Zinc finger and SCAN domain-containing protein 2 antibody (HPA007296) has been omitted due to cytoplasmic positivity. An alternative antibody (HPA024331), showing nuclear immunostaining pattern, has been added to the Protein Atlas.
• The Tumor necrosis factor-inducible gene 6 protein Precursor antibody (HPA007896) has been omitted due to nuclear positivity.
• The Endonuclease III-like protein 1 antibody (HPA008299) has been omitted due to cytoplasmic positivity. An alternative antibody (CAB025152), showing a nuclear immunostaining pattern, has been added to the Protein Atlas.
• The Breast cancer metastasis-suppressor 1 antibody (CAB010824) has been omitted due to general positivity. An alternative antibody (HPA019637), showing a more distinct immunostaining pattern in placenta, has been added to the Protein Atlas.
• The Neurofilament medium polypeptide antibody (HPA010900) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The Gastrotropin antibody (HPA012601) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The Neurofilament medium polypeptide antibody (HPA012976) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The Dual specificity protein phosphatase 2 antibody (CAB016341) has been omitted due to cytoplasmic positivity.
• The Zinc finger and SCAN domain-containing protein 21 antibody (HPA016948) has been omitted due to cytoplasmic positivity. An alternative antibody (HPA023591), showing a nuclear immunostaining pattern, has been added to the Protein Atlas.
• The Group 3 secretory phospholipase A2 Precursor antibody (HPA018314) has been omitted due to rare positivity. An alternative antibody (HPA021016), showing a more ubiquitous immunostaining pattern, has been added to the Protein Atlas.
• The Cyclin-A1 antibody (CAB019372) has been omitted due to diffuse cytoplasmic positivity.
• The Forkhead box protein P3 antibody (HPA003191 and HPA008383) have been omitted due to cytoplasmic positivity. An alternative antibody (CAB026301), showing nuclear immunostaining pattern, has been added to the Protein Atlas.
• The CD63 antigen antibody (CAB000062) has been removed from the protein atlas since it has been discontinued by the commercial distributor.
• The Alkaline phosphatase, placental type Precursor antibody (CAB000067) has been removed from the protein atlas since it has been discontinued by the commercial distributor.
• The Large Intestine Mucinous Antigen antibody (CAB000358) has been removed from the protein atlas since it has been discontinued by the commercial distributor.
• The Proto-oncogene protein c-fos antibody (CAB000461) has been removed from the protein atlas since it has been discontinued by the commercial distributor.
• The Kallikrein-6 Precursor antibody (CAB000463) has been removed from the protein atlas since it has been discontinued by the commercial distributor.
• The SIMA antibody (CAB000468) has been removed from the protein atlas since it has been discontinued by the commercial distributor.
• The Cystatin-B antibody (CAB000470) has been removed from the protein atlas since it has been discontinued by the commercial distributor.
• The Hepatocyte nuclear factor 4-alpha antibody (CAB001387) has been removed from the protein atlas since it has been discontinued by the commercial distributor.
• The Mitochondria antibody (CAB001516) has been removed from the protein atlas since it has been discontinued by the commercial distributor.
• The Prohibitin antibody (CAB001517) has been removed from the protein atlas since it has been discontinued by the commercial distributor.
• The Tubulin antibody (CAB001518) has been removed from the protein atlas since it has been discontinued by the commercial distributor.
• The GRB2-associated-binding protein 1 antibody (CAB002605) has been removed from the protein atlas since it has been discontinued by the commercial distributor.
• The CAB000026 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The CAB000033 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The CAB000044 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The CAB000046 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The CAB000049 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The CAB000050 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The CAB000056 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The CAB000061 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The CAB000138 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The CAB000302 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The HPA000519 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The HPA000639 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The HPA000754 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The HPA001217 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The HPA001245 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The CAB001717 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The CAB001810 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The HPA001839 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The CAB001997 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The HPA002357 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The HPA002539 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The HPA003009 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The HPA003034 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The HPA003052 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The HPA003065 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The HPA003181 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The HPA003182 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The HPA003212 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The HPA003214 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The HPA003285 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The HPA003532 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The HPA003540 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The HPA003550 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The HPA003644 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The HPA003652 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The HPA004008 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The CAB004085 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The HPA004110 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The HPA004115 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The CAB004271 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The HPA004709 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The HPA005736 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The HPA006013 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The HPA006766 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The HPA007969 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The CAB008641 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The CAB008642 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The CAB008643 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The HPA009419 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The CAB010402 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The HPA011072 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The CAB011453 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The HPA012158 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The CAB012703 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The CAB012908 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The HPA013409 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The HPA013767 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The HPA014796 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The CAB014879 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The HPA015013 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The CAB015367 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The CAB015377 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The CAB015395 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The HPA015509 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The CAB016533 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The CAB016726 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The CAB016789 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The HPA017390 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The HPA017595 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The HPA018452 antibody has been removed from the protein atlas due to target gene not found in Ensembl.
• The HPA018827 antibody has been removed from the protein atlas due to target gene not found in Ensembl.

Protein Atlas version 4.1 - 2008.12.03

• Gene synonyms are now included in the database. The synonyms are searchable and displayed on the gene/protein-page. The gene synonyms are derived from Ensembl.
• Western blot results with the validation score 3 (Single band larger than predicted size in kDa (+20%) but partly supported by predicted transmembrane region, signal peptide or by other available data.) have been moved from the validation category supportive (displayed as green) to the validation category uncertain (displayed as yellow).
• The A-kinase anchor protein 4 precursor antibody (HPA005949) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The Fructose-bisphosphate aldolase C antibody (HPA003282) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The Solute carrier family 40 member 1 antibody (HPA011124) was removed from the Protein Atlas due to lack of positivity in entercytes.
• The Synaptotagmin-like protein 4 antibodies (HPA001475 and HPA001589) were removed from the Protein Atlas due to lack of positivity in islet cells.
• The Tyrosine-protein phosphatase non-receptor type 7 antibody (CAB0009530) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The Bile salt export pump antibody (HPA0019035) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The Collagen alpha-3(VI) chain precursor antibody (CAB002307) has been omitted due to immunostaining in most tissues including epithelial cells.
• The NKG2-D type II integral membrane protein antibody (HPA001043) has been omitted due to diffuse cytoplasmic immunostaining.
• The Catenin alpha-1 antibody (CAB000107) has been omitted due to nuclear staining.
• The Cytokeratin AE1/AE3 antibody (CAB000025) has been omitted from the Protein Atlas due to representation of more than one gene.
• The E3 ubiquitin-protein ligase UBR4 antibody (HPA013394) has been omitted due to nuclear staining.
• The VIP peptides precursor antibody (CAB000573) was removed from the Protein Atlas due to lack of positivity in islet cells and periferial nerves.
• The NGFI-A-binding protein 1 antibody (HPA002738) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The Plexin-B2 precursor antibody (HPA003100) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• The Major prion protein precursor antibody (CAB005591) has been omitted from the Protein Atlas due to positivity in HEK293 cells.
• The Pericentrin antibody (CAB005888) has been omitted from the Protein Atlas due to nuclear staining.
• The Ephrin-B1 precursor antibody (CAB013501) has been omitted from the Protein Atlas due to nuclear staining.
• The Argininosuccinate synthase antibody (CAB001953) has been omitted from the Protein Atlas due to weak and sparse cytoplasmic staining.
• The DNA-binding protein inhibitor ID-3 antibody (CAB017119) has been omitted from the Protein Atlas due to cytoplasmic staining.
• The Mitogen-activated protein kinase kinase kinase kinase 2 antibody (HPA012120) has been omitted from the Protein Atlas due to lack of positivity in B cells.
• The Lysosomal-associated transmembrane protein 4B antibody (HPA014996) has been omitted from the Protein Atlas due to nuclear staining.
• The Transmembrane protein 70 antibody (HPA014446) has been omitted due to diffuse cytoplasmic positivity.

Protein Atlas version 4 - 2008.08.18

• [New] Fourth major release of the Human Protein Atlas with more than 6,000 antibodies and more than 5,700,000 images.
• [New] All human protein-coding genes (Ensembl v50.36) have been included in the protein atlas.
• [New] The proteins have now been classified according to a collection of protein classes.
• [New] The antigen sequence for all HPA antibodies is now disclosed and visualized on the target protein sequence.
• [Update] The search has been updated to make it possible to search for specific chromosomes, protein classes or protein expression patterns in cells.
• [Change] The CDC25A antibody (CAB002674) has been omitted due to weak immunostaining. An alternative antibody (HPA005855), showing a more distinct immunostaining pattern, has been added to the Protein Atlas.
• [Change] The E3 SUMO-protein ligase PIAS1 antibody (HPA005743) has been omitted due to diffuse cytoplasmic and sparse nuclear immunostaining. An alternative antibody (CAB012304), showing a more distinct nuclear immunostaining pattern, has been added to the Protein Atlas.
• [Change] The Protein CASP antibody (HPA003277) has been omitted due to non-reliable protein expression patterns (IHC).
• [Change] The Phosphatidylinositol 3-kinase regulatory subunit alpha antibody (HPA001569) has been omitted due to non-reliable protein expression patterns (IHC).
• [Change] The Neurogenic locus notch homolog protein 4 precursor antibody (CAB010183) has been omitted due to negative or weak cytoplasmic staining. An alternative antibody (CAB012331), showing a more distinct and ubiquitous immunostaining pattern, has been added to the Protein Atlas.
• [Change] The Sequestosome-1 antibody (HPA003196) has been omitted due to weak and diffuse staining in some cells. An alternative antibody (CAB004587), showing a more distinct and ubiquitous immunostaining pattern, has been added to the Protein Atlas.
• [Change] The Beta crystallin B1 antibody (HPA003101) has been omitted due to ubiquitous expression in most cells. The antibody should be eye specific.
• [Change] The Transcription factor E2F1 antibody (CAB000120) has been omitted due to negative or weak staining in most cells. An alternative antibody (CAB000329), showing a more distinct nuclear immunostaining pattern, has been added to the Protein Atlas.
• [Change] The T-cell surface glycoprotein CD3 zeta chain precursor antibody (CAB002721) has been omitted due to ubiquitous staining in most cells. Alternative antibodies (CAB004651 and HPA008750), showing a more distinct immunostaining pattern in inflammatory cells, have been added to the Protein Atlas.
• [Change] The Protein numb homolog (HPA002874) has been omitted due to lack of membranous staining in most cells. An alternative antibody (CAB011478), showing a more distinct membranous immunostaining pattern in most cells, has been added to the Protein Atlas.
• [Change] The Major histocompatibility complex, class II, DM beta antibody (HPA007113) has been omitted due to ubiquitous staining in most cells. Alternative antibody (HPA012298), showing a more distinct immunostaining pattern in inflammatory cells, has been added to the Protein Atlas.
• [Change] The Ephrin type-A receptor 7 precursor antibody (HPA000858) has been omitted due to negative or weak staining. An alternative antibody (CAB010496), showing a more distinct membranous immunostaining pattern, has been added to the Protein Atlas.
• [Change] The Sodium/potassium-transporting ATPase subunit beta-1 antibody (CAB001989) has been omitted due to cytoplasmic staining. An alternative antibody (HPA012911), showing a more distinct membranous immunostaining pattern, has been added to the Protein Atlas.
• [Change] The Nucleobindin-1 precursor antibody (CAB004677) has been omitted due to negative or weak staining. An alternative antibody (HPA008176), showing a more distinct ubiquitous cytoplasmic immunostaining pattern, has been added to the Protein Atlas.
• [Change] The Cullin-4B antibody (HPA003046) has been omitted due to cytoplasmic positivity. Other alternative antibodies (CAB017786 and HPA011880), showing a more distinct nuclear immunostaining pattern, has been added to the Protein Atlas.
• [Change] The Coagulation factor VIII precursor antibody (HPA001108) has been omitted due to absence of extra-cellular positivity. An alternative antibody (CAB018777), showing a more reliable immunostaining pattern, has been added to the Protein Atlas.
• [Change] The UDP-N-acetylhexosamine pyrophosphorylase antibody (HPA005897) has been omitted due to diffuse immunostaining pattern. An alternative antibody (HPA014659), showing a more reliable positivity, has been added to the Protein Atlas.
• [Change] The Caspase-2 precursor antibody (CAB002046) has been omitted due to nuclear and cytoplasmic positivity. An alternative antibody (CAB012175), showing cytoplasmic immunostaining pattern, has been added to the Protein Atlas.
• [Change] The Formimidoyltransferase-cyclodeaminase antibody (CAB001519) has been omitted due to diffuse and general cytoplasmic positivity. An alternative antibody (CAB016409), showing a more distinct cytoplasmic immunostaining pattern, has been added to the Protein Atlas.
• [Change] The Glycogen synthase kinase-3 beta antibody (CAB005033) has been omitted due to diffuse cytoplasmic positivity. An alternative antibody (CAB016263), showing a more distinct cytoplasmic immunostaining pattern in eg neuronal tissues, has been added to the Protein Atlas.
• [Change] The NF-kappa-B-repressing factor antibody (HPA001136) has been omitted due to the excistence of other redundant antibody (HPA001476).
• [Change] The Zinc finger Y-chromosomal protein antibody (HPA000723) has been omitted due to diffuse cytoplasmic positivity. An alternative antibody (HPA001748), showing nuclear immunostaining pattern, has been added to the Protein Atlas.
• [Change] The HPA000629 antibody has been omitted from the protein atlas due to overlapping antigen with antibody HPA0001862 (disagreement with the concept of independent antibodies for quality assurance).
• [Change] The HPA005694 antibody has been omitted from the protein atlas due to overlapping antigen with antibody HPA000634 (disagreement with the concept of independent antibodies for quality assurance).
• [Change] The HPA000403 antibody has been omitted from the protein atlas due to overlapping antigen with antibody HPA003060 (disagreement with the concept of independent antibodies for quality assurance).
• [Change] The HPA007983 antibody has been omitted from the protein atlas due to overlapping antigen with antibody HPA001383 (disagreement with the concept of independent antibodies for quality assurance).
• [Change] The HPA006077 antibody has been omitted from the protein atlas due to overlapping antigen with antibody HPA010873 (disagreement with the concept of independent antibodies for quality assurance).
• [Change] The HPA002035 antibody has been omitted from the protein atlas due to overlapping antigen with antibody HPA002127 (disagreement with the concept of independent antibodies for quality assurance).
• [Change] The HPA000829 antibody has been omitted from the protein atlas due to overlapping antigen with antibody HPA000764 (disagreement with the concept of independent antibodies for quality assurance).
• [Change] The HPA000539 antibody has been omitted from the protein atlas due to overlapping antigen with antibody HPA000452 (disagreement with the concept of independent antibodies for quality assurance).
• [Change] The HPA001506 antibody has been omitted from the protein atlas due to overlapping antigen with antibody HPA000289 (disagreement with the concept of independent antibodies for quality assurance).
• [Change] The HPA001006 antibody has been omitted from the protein atlas due to overlapping antigen with antibody HPA005552 (disagreement with the concept of independent antibodies for quality assurance).
• [Change] The HPA002034 antibody has been omitted from the protein atlas due to overlapping antigen with antibody HPA002192 (disagreement with the concept of independent antibodies for quality assurance).
• [Change] The HPA000368 antibody has been omitted from the protein atlas due to overlapping antigen with antibody HPA002925 (disagreement with the concept of independent antibodies for quality assurance).
• [Change] The HPA001230 antibody has been omitted from the protein atlas due to overlapping antigen with antibody HPA001625 (disagreement with the concept of independent antibodies for quality assurance).
• [Change] The HPA000951 and HPA000952 antibody has been omitted from the protein atlas due to overlapping antigen with antibody HPA001817 and HPA001832 (disagreement with the concept of independent antibodies for quality assurance).
• [Change] The Adenomatous polyposis coli protein antibody (CAB002211) has been omitted due to sparse cytoplasmic positivity in goblet cells. An alternative antibody (HPA013349), showing a more general distinct cytoplasmic immunostaining pattern, has been added to the Protein Atlas.
• [Change] The Alpha-type platelet-derived growth factor receptor precursor antibody (HPA004947) has been omitted due to unexpected positivity in some tissues. An alternative antibody (CAB018143), showing a more reliable immunostaining pattern, has been added to the Protein Atlas.
• [Change] The Sulfotransferase family cytosolic 1B member 1 antibody (HPA002107) images have been omitted and replaced with images from a more recent staining with the same antibody.
• [Change] The Interleukin-1 beta precursor antibody (HPA001410) has been omitted due to non-reliable nucleolar immunostaining pattern.
• [Change] The prothrombin precursor antibody (HPA002970) has been omitted due to unexpected positivity in leukocytes. Two alternative antibodies (CAB016780 and CAB018650), showing a more distinct immunostaining pattern in serum, have been added to the Protein Atlas.
• [Change] The C-X-C chemokine receptor type 3 antibody (HPA003189) has been omitted due diffuse nuclear staining. An alternative antibody (CAB017820), displaying a more reliable immunostaining pattern, has been added to the Protein Atlas.
• [Change] The Carcinoembryonic antigen-related cell adhesion molecule 5 precursor antibody (CAB000022) images have been omitted and replaced with images from a more recent staining with the same antibody.
• [Change] The Myeloperoxidase precursor antibody (CAB000059) images have been omitted and replaced with images from a more recent staining with the same antibody.
• [Change] The CAMP-responsive element modulator antibody (HPA001818) images have been omitted and replaced with images from a more recent staining with the same antibody.
• [Change] The Collagen alpha-1(III) chain precursor antibody (HPA007583) images have been omitted and replaced with images from a more recent staining with the same antibody.

Protein Atlas version 3.1 - 2008.02.15

• [New] A FAQ document (Frequently Asked Questions) has been added and is available as a link on the bottom of each page.
• [New] Each image has now been complemented with more tissue information such as T-number and M-number as defined by SNOMED.
• [Change] The term Staining intensity has been changed to Protein expression on several pages.
• [Change] The ETS1-associated protein 1 (EAP1) antibody HPA008797 has been removed due to weak and unspecific staining. An alternative antibody HPA008736 is available on the Protein Atlas.
• [Change] The Myeloid zinc finger 1 antibody (HPA001757) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• [Change] The E3 ubiquitin-protein ligase Praja1 antibody (HPA000595) stained images have been omitted and replaced with images from a more recent staining with the same antibody.
• [Change] The WD repeat protein 13 antibody (HPA000239) has been omitted due to non-reliable protein expression patterns (IHC), showing mainly cytoplasmic positivity. An alternative antibody (HPA000913), displaying distinct nuclear staining, has been added to the Protein Atlas.
• [Change] Medullar cells has been removed for adrenal gland.
• [Change] Lymphoid tissue has been renamed to lymphoid cells in appendix.
• [Change] Bone marrow poetic cells has been renamed to bone marrow poietic cells.
• [Change] Surface epithelial cells has been renamed to respiratory epithelial cells in bronchus.
• [Change] Non-neuronal cells has been renamed to glial cells in cerebral cortex.
• [Change] Surface epithelial cells (squamous) has been renamed to squamous epithelial cells in cervix, uterine.
• [Change] Endometrium has been renamed to corpus, uterine.
• [Change] Cells in endometrial stroma/ECM has been renamed to cells in endometrial stroma in corpus, uterine.
• [Change] Cells in myometrium/ECM has been removed for corpus, uterine.
• [Change] Surface epithelial cells has been renamed to squamous epithelial cells in esophagus.
• [Change] Non-neuronal cells has been renamed to glial cells in hippo campus.
• [Change] Cells in tubuli has been renamed to cells in tubules in kidney.
• [Change] Non-neuronal cells has been renamed to glial cells in lateral ventricle.
• [Change] Follicle cells (cortex) has been renamed to reaction center cells in lymph node.
• [Change] Non-follicle cells (paracortex) has been renamed to lymphoid cells outside reaction centra in lymph node.
• [Change] Surface epithelial cells has been renamed to respiratory epithelial cells in nasopharynx.
• [Change] Surface epithelial cells has been renamed to squamous epithelial cells in oral mucosa.
• [Change] Exocrine pancreas has been renamed to exocrine glandular cells in pancreas.
• [Change] Cells in ductus seminiferus has been renamed to cells in seminiferus ducts in testis.
• [Change] Follicle cells (cortex) has been renamed to reaction center cells in tonsil.
• [Change] Non-follicle cells (paracortex) has been renamed to lymphoid cells outside reaction centra in tonsil.
• [Change] Surface epithelial cells has been renamed to squamous epithelial cells in tonsil.
• [Change] Surface epithelial cells has been renamed to urothelial cells in urinary bladder.
• [Change] Surface epithelial cells has been renamed to squamous epithelial cells in vagina.
• [Change] Surface epithelial cells has been renamed to squamous epithelial cells in vulva/anal skin.
• [Change] Colo-rectal cancer has been renamed to colorectal cancer.

Protein Atlas version 3 - 2007.10.09

• [New] Third major release of the Human Protein Atlas with more than 3.000 antibodies and more than 2.800.000 images.
• [New] Section for immunoflourescence staining of cell lines and confocal scanned images.
• [New] Advanced search functionality enabling expression pattern search.
• [New] Sort IHC tissues by alphabetic or histogenic order.
• [New] Antibody specifility diagrams are now available for each HPA antibody based on array experiments. The diagrams can be found on the antibody info page.
• [New] Western blot images are showed on selected antibodies on the antibody info page.
• [Change] The SMC1 alpha protein antibody (HPA002855) has been omitted due to weak immunostaining. An alternative antibody (HPA005499), showing a more distinct immunostaining pattern, has been added to the Protein Atlas.
• [Change] The TNF-R2 antibody (CAB002614) has been omitted due to a nuclear staining pattern. An alternative antibody (HPA004796), showing cytoplasmic and membranous positivity, has been added to the Protein Atlas.
• [Change] The IL-1R-1 antibody (HPA001237) has been omitted due to a nuclear staining pattern. An alternative antibody (CAB007779) has been added to the Protein Atlas.
• [Change] The LTF antibody (HPA001833) has been omitted due to deficient immunostaing with expected extra-cellular positivity. An alternative antibody (CAB008645) has been added to the Protein Atlas.
• [Change] The FERM and PDZ domain-containing protein 3 antibody (HPA000830) has been omitted due to unspecific staining pattern.
• [Change] The MMP-3 antibody (CAB002747) has been omitted due to low quality immunostaining pattern with only sparse positivity in mucous producing cells.
• [Change] The AMOT antibody (CAB003708) has been omitted due to lack of expected positivity in endothelial cells.

Protein Atlas version 2 - 2006.10.30

• [New] Second major release of the Human Protein Atlas with more than 1.500 antibodies and 1.000.000 images.
• [New] Cell profiles have been added to complement the tissue profiles. The new profiles consist of 47 cell lines and 12 primary cells that have been stained with HPA antibodies and evaluated using automated image analysis. The results are presented at the bottom of the expression profile-page for almost every antibody.
• [Change] Due to late finding of an incorrect molecular weight of the antigens for HPA001340 and HPA001660, these antibodies were removed.
• [Change] Due to weak and unspecific staining using the CDC2 antibody, CAB002435, a new immunostaining and subsequent annotation has been performed using the alternative antibody, CAB003799.

Protein Atlas version 1.2 - 2006.03.13

• [Change] The underlying algorithms for color code representation of negative, weak, moderate and strong staining has been modified. In the updated version, an immunostaining of less than 25% of the recorded cell type has been given less weight compared to the previous version. The result provides a more accurate display of the represented immunostained cell population.
• [Change] In the previous version, tissues with one or several cell types missing were shown as a negative (white) color code. In the present version, this has been changed so that all cell types now displayed as negative (white) correctly represent existing cell types that lack immunohistochemical staining. The color code black (Not representative) has now been extended to include both not representative images as well as images where cell types are missing. The overall result will be an increase of displayed cell types as "Not representative" (black).
• [Change] The explanation for a black color code on the summary page has been changed from "No images" to "Not representative".
• [Change] A new design of the table displaying the splice variants for each gene.
• [Update] Due to a weak and unspecific staining of the Integrin antibody, CAB003434, a new immunostaining has been performed using the same antibody. Images and annotation has been updated and the old version, CAB000127, has been removed.

Protein Atlas version 1.1 - 2005.11.11

• [Change] Changes have been made in the presentation of annotated localization patterns. Previous version included 4 different parameters for describing subcellular localization of protein expression: i) nuclear, ii) cytoplasmic, iii) membrane and iv) extra cellular. In the present version cytoplasmic and membraneous localization have been merged so that the output parameters now are i) nuclear, ii) cytoplasmic and/or membraneous. Due to the level of resolution using enzyme-based immunohistochemistry it is not possible to distinguish between cytoplasmic and membraneous localization in cells with a small cytoplasm. Cytoplasmic and membraneous localization has consequently been changed to one shared output parameter. Extra cellular localization has been omitted as a localization parameter given for a cell type. Corresponding text concerning annotation in “about protein atlas” has been modified accordingly.
• [Change] A new summary page has been created. Previous version included two different summary pages, one for normal tissues and one for cancer tissues as well as a summary page containing all antibody information. In the present version the summary page contains a short gene description and a summary of both normal and cancer tissues.
• [New] A new tab on the start page has been inserted. The new tab represents a “submission of antibodies” and contains a call for antibodies, information and an application form. Previous version included a tab “collaborations” which has been omitted.
• [Update] Reliabilty scores have been curated for a subset of antibodies in the protein atlas since new data has allowed for detailed validation. A validation comment text has been added in these cases.
• [New] The possibility to reference or link into a particular antibody in the Protein Atlas has now been simplified. The Protein Atlas now supports links in the following two new formats: HUGO ID and Ensembl gene ID. Examples of the new URLs:
  http://www.proteinatlas.org/tissue_profile.php?hugo_id=bmx
  or
  http://www.proteinatlas.org/tissue_profile.php?ensembl_gene_id=ENSG00000102010
• [New] Version history (this text) has been added as text under the tab “about protein atlas”.

Protein Atlas version 1 - 2005.08.29

• First release of the Protein Atlas. Atlas content: 718 antibodies and 413,568 images